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ABSTRACT OF THE DISSERTATION
Dissemination of the apicomplexan parasite, Toxoplasma gondii
by
Lisa LaRhea Drewry
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2019
Professor L. David Sibley, Chair

The parasitic protist Toxoplasma gondii is a common pathogen of rodents and felines that
also infects humans. The most severe clinical manifestations of toxoplasmosis in humans derive
from the systemic dissemination of T. gondii, during which the parasite penetrates biological
barriers and accesses protected host compartments such as the central nervous system. T. gondii
dissemination is enabled by the intrinsic gliding motility of extracellular parasites, which allows
for travel to new host cells and tissues, and also powers the invasion of diverse host cells
including migratory leukocytes. Dissemination is further advanced when migrating infected
leukocytes shuttle intracellular parasites to new locations as they traffic throughout the host.
All T. gondii gliding motility and host cell invasion was long presumed to be powered by
the work of a parasite actin-myosin motor. The possibility of alternative gliding and invasion
mechanisms was suggested by the development of inducible Cre-Lox technology that facilitated
inducible disruption of genes thought to encode critical components of the T. gondii invasion
machinery, including the parasite actin gene ACT1. To determine whether ACT1-independent
viii

invasion was likely, inducible Δact1 parasites were examined for uniformity of ACT1 protein
depletion. Individual parasites with residual ACT1 protein persisted long after inducible ACT1
excision. Suggesting the residual ACT1 content of these parasites was functionally relevant, the
invasion of Δact1 parasites was highly sensitive to an actin polymerization inhibitor. Parasite
invasive ability was also found to negatively correlate with the length of time parasites were
subjected to ACT1 depletion. Although the existence of ACT1-independent invasion
mechanisms cannot be formally excluded, they do not appear to comprise robust alternatives to
actin-dependent gliding and invasion in T. gondii.
As the most abundantly infected circulating leukocyte during murine toxoplasmosis,
monocytes have been theorized to be poised to deliver intracellular T. gondii across the bloodbrain barrier and into the central nervous system. However, in vivo evidence supporting this
theory was scarce. In vitro models had demonstrated that infection could alter the motility of
monocytes when interacting with endothelial vasculature. However, whether infected monocytes
could efficiently traverse the specialized endothelium that comprises the blood-brain barrier had
not been tested, nor had the ability of infected monocytes to migrate through the tissue
environments where T. gondii is first encountered. Models of peripheral and blood-brain barrier
endothelium were used to show that infection markedly inhibited monocyte transendothelial
migration. In contrast, infected monocytes and macrophages migrated through three-dimensional
matrices in vitro and collagen-rich tissues in vivo with enhanced efficiency. Enhanced tissue
migration relied on host Rho/ROCK and formin signaling, and the secreted T. gondii kinase
ROP17. In a murine model, infection with Δrop17 parasites that fail to enhance tissue migration
resulted in delayed dissemination and prolonged mouse survival. These results implicate
monocytes in advancing the tissue spread of T. gondii during in vivo dissemination.
ix

Chapter 1: Introduction

This chapter was composed by LLD and revised according to comments from LDS.
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Apicomplexan parasites
Many diseases of medical and veterinary significance are caused parasites belonging
to the Apicomplexa phylum. Plasmodium species cause malaria, which infects about 200 million
and kills over 500,000 annually (1). Cryptosporidiosis was recently realized to be one of the
most common causes of severe diarrheal disease in young children (2,3). Eimeria (4,5) and
Theileria species (6) infect poultry and ruminant livestock, leading to substantial economic
losses. Toxoplasma gondii infection causes toxoplasmosis in a wide array of human and animal
hosts (7).
Life cycle of T. gondii
Like most of the Apicomplexa, T. gondii is an obligate intracellular parasite. However,
unlike most of the Apicomplexa, T. gondii replication is not restricted to a narrow range of hosts
or cell types. T. gondii is primarily a pathogen of rodents and felines, but can infect essentially
any warm-blooded vertebrate (8). Within these hosts, T. gondii can invade and replicate within
any nucleated cell type.
T. gondii infections are typically orally acquired upon ingestion of parasite cysts.
Ingested cysts can be either sexual stage oocysts or asexual tissue cysts. As the definitive host of
T. gondii, felines are the only hosts in which the parasite can undergo sexual reproduction (7).
Felines are very sensitive to infection with asexual tissue cysts (9), and shed oocysts in their
feces after primary T. gondii infections (10). Shed and sporulated oocysts contain eight
sporozoites, are highly resistant to environmental stresses, and remain infectious for months
(11,12). Intermediate hosts can acquire toxoplasmosis through the oral-fecal contact, by
ingesting water contaminated with oocysts, or through the consumption of other intermediate
hosts harboring tissue cysts (7,11).
2

Once ingested, the bradyzoites contained within tissue cysts or sporozoites contained
within oocysts invade the intestinal lamina propria and differentiate into tachyzoites. Tachyzoites
undergo rapid asexual reproduction in many host compartments and their proliferation causes the
symptoms of acute toxoplasmosis (7). Immune pressure leads tachyzoites to differentiate into
bradyzoites. Bradyzoites form tissue cysts, in which they are largely quiescent but undergo
periods of cyclical replication (7,13). Tissue cysts resist immune clearance and can persist for the
life of the host, causing a life-long asymptomatic infection. Tissue cysts can be formed in many
tissues, but are predominantly found in long-lived tissues such as those of the central nervous
system (CNS) and skeletal muscle (7,14,15). Whether cysts are preferentially formed in the CNS
or simply persist there more efficiently due to the immuno-specialized nature of the CNS
remains a matter of active debate (16).
To replicate during tachyzoite proliferation, T. gondii enters host cells using an active
penetration mechanism that relies on parasite actin and myosin (17). This process results in the
creation of a non-fusogenic parasitophorous vacuole derived from the host cell membrane (18).
The internalized parasite replicates within the parasitophorous vacuole via endodyogeny and
emerges about 48 hours later via an active egress process that lyses the host cell (19). After
egress, extracellular tachyzoites use gliding motility to locomote to a new host cell and begin the
invasion and replication cycle anew.
Toxoplasmosis in humans
Humans contract toxoplasmosis primarily though the consumption of undercooked meat
harboring tissue cysts or by ingesting food or water contaminated with oocysts. Although the
specific route of infection cannot usually be established, epidemiological studies show that water
and meat harboring T. gondii oocysts or tissue cysts is relatively common in the United States
3

(7,11). Interestingly, a study of congenital toxoplasmosis cases in the United States indicated that
the majority of the mothers were infected with oocysts as evidenced by the presence of
antibodies specific to sporozoite stages (20). Infections can also be transmitted from pregnant
mothers to the developing fetus, and within transplanted organs (7).
In immunocompetent individuals, acute toxoplasmosis is a relatively benign infection
that often goes unnoticed as it presents with minor flu-like symptoms (7). However, the infection
is a major risk to the immunocompromised. In such patients, toxoplasmic encephalitis is one of
the most severe disease manifestations and lethal if not promptly treated (7,21,22). Maternalfetal transmission, particularly in the first and second trimesters, causes congenital infections that
can result in severe birth defects or fetal death (7). Both congenital and postnatal infections can
also lead to ocular disease (7). The parasites’ ability to spread beyond its initial intestinal niche
thus poses substantial risk to human hosts.
Even immunocompetent hosts capable of suppressing the growth of tachyzoites during
acute toxoplasmosis do not actually clear the infection and instead harbor lifelong asymptomatic
chronic infections. Chronic infections are wide-spread, with seropositivity rates suggesting over
half the human population in parts of South America and Europe to be infected (23). If
chronically infected individuals become immunocompromised, tissue cysts can lead to a
recrudescent infection caused by the dedifferentiation of bradyzoites into proliferative
tachyzoites (7). In this scenario, the preponderance of CNS-localized tissue cysts leaves the host
at risk for toxoplasmic encephalitis.
Although there is no vaccine against toxoplasmosis, treatments options are available for
patients experiencing severe acute disease. The most common regimen is combination
sulfadiazine and pyrimethamine, supplemented with folinic acid (7). Unfortunately, the high
4

therapeutic doses of these agents required for toxoplasmosis treatment yields substantial host
toxicity. In addition, none of the available regimens have any activity against the bradyzoite
tissue cysts that cause chronic infections. Moreover, these regimens are not suitable for use
during pregnancy. Spiramycin is used in Europe to treatment maternal infections, but its efficacy
remains highly uncertain (7). Accordingly, the identification of therapeutics suitable for use
during pregnancy and with efficacy against chronic infections would be a significant clinical
advance.
Dissemination kinetics
T. gondii infections initiate when hosts ingest encysted parasites in the form of either
bradyzoite tissue cysts or oocysts shed by felines (24). The acidic environment of the stomach
triggers excystation (25), during which sporozoites emerge from oocysts and bradyzoites from
tissue cysts (Fig. 1.1). Both sporozoites and bradyzoites enter the small intestine and access the
lamina propria by traversing intestinal epithelial enterocytes (Fig. 1.1). In mice orally infected
with high doses of oocysts, sporozoites were detected in the apical ends of intestinal enterocytes
by 2 hours post infection (14). By 6 hours post oocyst feeding, sporozoites were primarily
detected in the lamina propria, but also found in the basal portion of enterocytes (14). The
rapidity with which parasites reach the lamina propria suggests that T. gondii is capable of
directly traversing the intestinal epithelium without replicating within enterocytes. This
interpretation is supported by more recent in vitro and ex vivo studies that showed that T. gondii
tachyzoites were capable of both invading and traversing through intestinal epithelium (26). In
mice orally inoculated with bradyzoites liberated from tissue cysts, parasites were similarly
detected within intestinal enterocytes and in the lamina propria within 3 hours (15). Although
parasites are liberated from cysts in the stomach, invasion seems to be concentrated in the ileal
5

distal portions of the intestine, as indicated by studies examining parasite distribution in mice fed
oocysts (14,27) or bradyzoites (15). The mechanistic basis for parasites’ preferential invasion of
distal small intestine remains unexplored.
Although able to directly traverse intestinal epithelium, once in the lamina propria, T.
gondii is primarily intracellular and replicative. Transmission electron microscopy analysis
showed that parasites in the lamina propria 12-18 hours post oocyst feeding were
morphologically consistent with tachyzoites and had replicated. These parasites were primarily
intracellular and contained within parasitophorous vacuoles. They were found within essentially
all cells of the lamina propria, including lymphocytes, plasma cells, macrophages, neutrophils,
eosinophils and fibroblasts (14). More recent work used flow cytometry to quantify parasite
distribution 3 days after tissue cyst feeding. Parasites were again detected in a wide range of cells
including macrophages, monocytes, neutrophils, B cells, CD4+ T cells, CD8+ T cells, CD11b+
DCs, CD8α+ DCs, CD4-/CD8α- DCs, and plasmacytoid DCs, but most abundantly in nonleukocytes, macrophages, monocytes, and neutrophils (28).
Parasites continue to replicate in the lamina propria but also rapidly spread to secondary
lymphoid tissues. Parasites were detected within Peyer’s patches and mesenteric lymphoid nodes
with 8 hours of feeding mice heavy doses of oocysts (14,27) or bradyzoites (15). Studies using
more moderate doses of tissue cysts detected parasites within mesenteric lymph nodes and
Peyer’s patches 2-3 days post inoculation (28,29).
After spreading to secondary lymphoid tissues, T. gondii goes on to invade essentially all
distal organs of the host. Various studies report detection in the lungs at 4-5 days post oral
infection with bradyzoites or tissue cysts (14,15,27). First infection of the brain is consistently
placed at 6-8 days post oral infection with either oocysts or tissue cysts (14,15,27,29,30).
6

Whether oocyst- and tissue cyst-initiated infections closely mirror each other in dissemination
routes has not been rigorously explored. However, both infection modes seem to result in central
nervous system invasion in similar time frames, with minimal influence from the size of initial
inoculum on the eventual CNS burden. The disconnect between inoculum dose and CNS burden
likely stems from the peak burden during acute infection being primarily determined by the
effectiveness of host immune control.
Experimental models of toxoplasmosis often infect mice through intraperitoneal
tachyzoite injection as this easily cultivated stage does not tolerate the acidic environment of the
stomach. Curiously, such intraperitoneal tachyzoite injections also lead to parasites accessing the
central nervous system on the 6-8 day time-frame (30,31) typical of oral cyst inoculation.
However, a different route to the CNS may be used as this infection model bypasses the
intestinal lamina propria and migratory leukocytes initially encountered in natural infections.
Basis of systemic and CNS dissemination
The impressive spread of T. gondii from its initial nidus in the intestinal lamia propria to
essentially all tissues and organs of the host likely relies on both the gliding motility of
extracellular parasites (32) and the shuttling of intracellular parasites by motile host cells (33).
Circulatory and lymphatic vasculature could both serve as conduits that enable intracellular and
extracellular parasites to rapidly access tissues highly distal to the initial infection nidus in the
intestinal lamina propria.
Several early studies speculated that rapid dissemination following cyst feeding must be
driven by travel through lymphatics as they failed to detect T. gondii present in the bloodstream
(34,35). However, these same authors reported early infection of the spleen (34), which would
presumably result from hematogenous spread as the spleen lacks afferent lymphatics. Several
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other studies confirmed early infection of the spleen (14,15,27). Moreover, a contemporaneous
study using a more sensitive cat bioassay detected infectious parasites in the blood one day
following bradyzoite feeding, albeit with heavy inoculum doses (15). More recent studies fed
mice physiological doses of tissue cysts and detected parasitemia within 4-5 days of inoculation
using quantitative PCR (29) or flow cytometry (30). Hematogenous or lymphatic spread of T.
gondii from the lamina propria to distal sites thus are both plausible dissemination routes.
Defining the route by which T. gondii accesses the central nervous system has been of
high interest due to the severe clinical consequences of toxoplasmic encephalitis. Within the
brain, T. gondii cysts are primarily found in the cerebral cortex and more frequently in grey
matter than white matter (36,37). Early in vitro studies suggested that T. gondii might efficiently
and even preferentially invade astrocytes (38,39). However, in vivo studies in mice showed that
CNS cysts are overwhelmingly found within neurons, and very occasionally oligodendrocytes,
and this pattern is unlikely to derive from clearance of parasites within astrocytes (36,40,41). A
study of recrudescence in mice reported that re-activating parasite cysts are found primarily near
microvasculature (37). T. gondii cysts were also noted to predominantly localize to the brain
parenchyma and not meninges or circumventricular areas. This distribution led to the proposal
that T. gondii accesses the brain by traversing the blood-brain barrier (37). However, these
studies considered cyst location weeks to months after initial CNS entry (36,37). Whether cysts
form and mature at or near the initial site of CNS entry by the founder parasite is unknown, and
evidence suggests that bradyzoites do occasionally escape tissue cysts and migrate to new sites
(42). Moreover, no rigorous studies have yet examined whether the blood-CSF barrier (43) or
recently described brain lymphatics (44,45) could be used by T. gondii to access the CNS or
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spread once within it. The blood-brain barrier is thus currently the most promising possible
portal for T. gondii to enter the CNS, but other avenues are also possible.
Actin-dependent parasite gliding motility
T. gondii and other apicomplexans use a parasite-powered process termed gliding
motility to both move as extracellular parasites and invade host cells. Briefly, in this process,
rearward translocation of transmembrane adhesin proteins secreted from the parasites’
micronemal organelles powers forward movement. If this process is coupled to host cell
attachment at the parasites apical (anterior) end, the power of gliding motility can propel the
parasite into the cell. Gliding motility promotes dissemination both by enabling parasites to
spread while extracellular and by powering productive invasion of diverse host cells, including
highly motile leukocytes.
Extracellular gliding
Extracellular tachyzoites use gliding motility to locomote between host cells. Early
descriptions of this behavior noted three distinct forms of tachyzoite gliding on glass surfaces:
corkscrew-like helical gliding, circling gliding, and twirling (46). Because helical gliding most
efficiently produces net displacement of the parasite, it has been speculated to constitute
productive gliding while circling and especially twirling may simply be failures to helical glide.
Consistent with this idea, helical gliding is the only form that leads to invasion (46).
Furthermore, parasites embedded in three-dimensional matrigel matrices meant to model
extracellular matrix overwhelmingly glide in helical corkscrews (47). Forward translocation via
helical gliding motility is quite efficient, occurring at rates of 1-10 micron/sec (46,48,49).
During gliding, forward movement is produced by the rearward translocation of
transmembrane parasite adhesins. The adhesins are discharged at the apical end of the parasite
9

from micronemal secretory organelles in a calcium-regulated process (50-52). Micronemal
adhesins are transmembrane proteins that possess extracellular domains that interact with surface
substrates and cytoplasmic tails that interact with the parasite’s cytoskeleton (53). The linkage of
substrate-contacting micronemal adhesins to the cytoskeleton allows a complex termed the
glideosome to power forward movement by translocating the adhesins in the reverse direction
(54,55). Power for this process is produced by concerted action of a small parasite myosin (56)
with parasite actin (17).
Invasion
In contrast to most intracellular pathogens, T. gondii invasion of host cells is primarily a
pathogen-driven process. Invading T. gondii parasites do not enter host cells via endocytosis or
phagocytosis or induce dramatic host membrane rearrangements. Instead, the parasite uses
gliding motility to actively propel itself into host cells (49). This process is very rapid and
typically occurs in under a minute (57). As parasites enter the host cell, they undergo a dramatic
constriction at their interface with the host cell. This constriction appears as a ring through which
parasites appear to squeeze and is often termed the moving junction (58). Some subtle
rearrangements of cortical host actin are also observed at the parasite-host moving junction
interface (59,60). Whether the redistribution of host actin at the moving junction facilitates
parasite entry or simply reflects rearrangements in cortical actin forced by the dramatic inversion
of the host membrane during invasion remains unclear. However, the force for entry appears to
primarily derive from the parasite ACT1-MYOA glideosome (17).
Invasion is mediated by adhesive events enabled by sequential secretion from the
parasites microneme and rhoptry organelles (61,62). The micronemal adhesins involved in
gliding motility facilitate initial attachment to the host cell. Following initial attachment,
10

rhoptries are discharged. The rhoptry proteins RON2, RON4, and RON5 are secreted into the
host cell and localize to the moving junction (63). RON2 traverses the host cell membrane and at
an ectodomain contacts the micronemal adhesion AMA1 (64,65). The cytosolic portion of RON2
forms a complex with RON4 and RON5, which engages the host cell’s cytoskeleton (66). This
linkage allows the parasite to exert the force of gliding motility to penetrate into the host cell, as
evidenced by the dual reliance of gliding and invasion on parasite but not host actin
polymerization (61,67). The host cell’s membrane is inverted where the parasite engages and
transformed into the parasitophorous vacuole in which T. gondii will replicate. During this
process, the membrane is modified to produce a non-fusogenic vacuole that protects the
replicating parasites from endosomal or lysosomal-mediated destruction (18,49).
Potential for alternative invasion mechanisms
The adaptation of inducible Cre-Lox technology for use in T. gondii enabled the creation
of stable knockout parasite lines for several genes thought to be essential, including T. gondii
myosin (MYOA) and the micronemal adhesin AMA1 (AMA1), as well as an inducible knockout
line for T. gondii actin (ACT1) (68-70). The lytic growth cycle of T. gondii cannot proceed
without invasion (19). Accordingly, the ability of ΔmyoA and Δama1 parasites to grow in cell
culture was initially speculated to comprise evidence of an intact invasion pathway that
functioned independently of the MYOA-ACT1-powered glideosome (68,69). As the sole actin
present in T. gondii (67), ACT1 plays critical roles in cytoskeletal function and division and is
thus, not surprisingly, truly essential (68). However, residual motility and invasive ability in
inducibly Δact1 parasites were suggested to be further evidence of alternatives to glideosomepowered invasion in T. gondii (68,69). Given the ability of T. gondii to invade an unusually
diverse array of host cells and penetrate nearly all biological barriers (71), the concept of the
11

parasite maintaining multiple motility and invasive strategies was intriguing. In particular, an
alternative invasion pathway that does not lead to host cell lysis could plausibly help T. gondii to
more effectively exploit leukocyte trafficking for dissemination by allowing parasites to be
shuttled within migrating leukocytes for time periods longer than the typical lytic cycle.
Initial investigations of glideosome-dependent invasion quickly identified functional
redundancies in the T. gondii genome as likely explanations for the dispensable nature of MYOA
and AMA1. In addition to diminishing the efficiency of T. gondii invasion, MYOA deletion
prevented the subsequent excision of the gene encoding for splice variants of an alternative
parasite myosin, MYOB and MYOC (69). Following studies determined that an alternative
glideosome based on the MYOC splice variant compensated for MYOA loss and allowed
invasion in ΔmyoA parasites (72). Similarly, analysis of Δama1 parasites found that upregulated
homologs compensated for the loss of function of AMA1-RON2 linkage in the glideosome (73).
The pleiotropic roles for ACT1 in the life cycle of T. gondii complicate establishing
whether ACT1 is specifically required during invasion. All studies agree that Δact1 parasites
exhibit severe defects in both gliding and invasion, with both processes reduced at least 10-fold
relative to wild-type parasites (68,69). However, ACT1 has proven refractory to stable deletion.
Accordingly, these studies have examined parasites following rapamycin induction of Cremediated excision of a floxed ACT1f allele, in which a YFP reporter is used to identify parasites
that have undergone ACT1f excision. Complicating analysis, this system often yields rather low
rapamycin-induced excision frequency (68,69) and can also produce spontaneous excision events
at a low rate. How effectively the pools of inducible Δact1 parasites that have been studied
approximate true phenotypic nulls was thus unclear. Initial studies used immunostaining as a
rough qualitative estimate for the completeness of ACT1 depletion in inducible Δact1 parasites
12

and showed marked reduction, albeit to an unquantified degree (68,69). Notably, T. gondii actin
polymerizes in an unusual isodesmic manner that lacks a critical concentration required to
support the generation of F-actin (74,75). Accordingly, it is plausible that even very low levels of
residual ACT1 might suffice to support invasion.
ACT1 function has also been interrogated by perturbing polymerization dynamics, rather
than direct genetic knockout. Such approaches showed that conditional depletion of the T. gondii
formin FRM1 (76), actin depolymerizing factor ADF (77), and profilin (76) disturbed gliding
and invasion. Expression of ACT1 transgenes mutated to produce longer and more stable
filaments than that typical of the parasite’s natural isodesmic filaments also led to aberrant
parasite gliding (78). These studies all point to an important role for parasite actin in gliding and
invasion. Whether the residual gliding and invasion observed in inducible Δact1 parasites reflect
an alternative motility pathway or simply the incomplete removal of ACT1 protein in some
parasites in the analyzed pools thus remained uncertain.
Trojan horse dissemination
Immune responses are obviously critical to controlling microbial infections. However,
many pathogens have evolved the ability to exploit leukocyte trafficking as a means of
promoting dissemination. This strategy can enable enteric pathogens to spread beyond the
gastrointestinal tract (79). For example, Salmonella bacteria can rapidly escape their initial
intestinal niche and enter the bloodstream within CD18-expressing monocytes by using the
secreted effector SrfH to stimulate motility (79-81). Pathogen-harboring Trojan horses can also
breach the blood-brain barrier, providing access to the immuno-specialized CNS compartment
(33). Listeria monocytogenes invades the CNS when infected phagocytes traffic to the brain
while carrying intracellular bacteria (33,82-84). The pathogenic yeast Cryptococcus neoformans
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can also cross the blood-brain barrier within monocytes and macrophages acting as Trojan horses
(85-89). Among protozoan parasites, Leishmania species modulate adhesion and chemokine
receptor expression in phagocytes including macrophages and dendritic cells, which is theorized
to promote dissemination through host tissues (90-92).
Throughout in vivo infections, T. gondii parasites encounter and invade a plethora of
motile leukocytes that could be co-opted as dissemination-promoting Trojan horses. Various
reports propose DCs, neutrophils and monocytes as potential Trojan horses. Given the diverse
tissue compartments and biological barriers invaded by T. gondii, each of these leukocyte types
may contribute to systemic T. gondii spread by advancing dissemination at distinct stages of the
infection.
Dendritic cells as Trojan horses
Of all leukocytes, the ability of DCs to promote T. gondii dissemination has been
explored in the most detail. DCs are antigen presenting cells that are primarily positioned in
peripheral tissues, where they acquire antigens that they subsequently deliver for presentation to
T cells in secondary lymphoid tissues (93).
The distribution of DCs suggests that they would be well-poised to promote T. gondii
dissemination by advancing spread through tissues. Consistent with this idea, an analysis of
parasite distribution after mice were orally inoculated with tissue cysts reported that T. gondii
was primarily detected associated with CD11c+ cells in intestinal lamina propria and mesenteric
lymph nodes early in infection, but then switched to preferential association with CD11b+
monocytes when in the bloodstream at 1 week post infection (29). Curiously, though, another
study reported that at three and six days post inoculation with oral tissue cysts, parasites in the
intestinal lamina propria were predominantly found within non-leukocytes (37-52%), followed
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by monocytes, macrophages and neutrophils, which cumulatively accounted for about 1/3 of
infected cells at both time points (28). In this study, infected DCs were quite scarce, comprising
less than 5% of all infected cells in the intestinal lamina propria, Peyer’s patches, and mesenteric
lymph nodes at both three and six days post inoculation (28).
Several independent studies point to a role for DCs in promoting dissemination. In mice
infected intraperitoneally with T. gondii, peritoneal CD11c+ Gr-1+ DCs were preferentially
infected and then recruited to the spleen, where they comprised more than half of the infected
cell population, suggesting these cells might have delivered parasites to the spleen (94). Another
report showed that T. gondii infection of human monocyte-derived DCs and murine bone
marrow-derived DCs induced an in vitro hypermotility phenotype characterized by increased DC
migration across plastic transwell membranes, and increases in the velocity and distance traveled
by DC crawling on 2-D substrates (95). Mice inoculated intraperitoneally with T. gondii-infected
bone marrow-derived DCs exhibited higher parasite burdens and more rapid detection in the
brain (1 vs 3 days post infection), compared to intraperitoneal inoculation with a matched
quantity of extracellular parasites, suggesting that the migration of infected DCs can promote
dissemination in vivo (95). Further studies established that the magnitude of the DC
hypermigration phenotype varied with parasite genetic lineage (96), such that a less pronounced
enhancement was observed upon infection with parasites of a hypervirulent type I lineage that
possess higher rates of intrinsic motility as extracellular parasites (26). Adoptive intraperitoneal
transfer of DCs infected with less intrinsically motile type II and III T. gondii strains (26) led to
mice exhibiting parasite burdens similar to that caused by infection with type I lineages expected
to exhibit a virulence advantage (96). This suggests that DC-aided dissemination might be more
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important for T. gondii lineages with less robust extracellular motility, particularly type II and III
lineages (96).
The precise mechanistic basis for hypermigration in T. gondii-infected DCs remains
unclear. However, the DC hypermigration phenotype has been shown to be accompanied by
rapid cytoskeletal changes that start within ten minutes and include dissolution of adhesive
podosomes, redistribution of integrins and F-actin, and moderate upregulation of CCR7
expression (97). The enhanced migration of infected DCs requires signaling through GABA
receptors to a Cav1.3 voltage-dependent calcium channel (98,99). The rapid onset of the
hypermigration phenotype suggests control at the level of signaling rather than transcription or
translation. Consistent with this, one study reported that heterologous expression of a T. gondii
14-3-3 protein was sufficient to induce hypermigration in DCs, as was treatment of DCs with
recombinant Tg14-3-3 (100). Unfortunately, Tg14-3-3 is likely an essential gene (101) and
proved refractory to deletion (100). Accordingly, it is unclear whether Tg14-3-3 is required for
parasites to enhance DC migration. Moreover, 14-3-3 proteins are adaptor proteins expressed by
mammalian cells and play extensive roles in cytoskeletal regulation (102). Accordingly, it is
uncertain whether enhanced DC migration in response to treatment with recombinant Tg14-3-3
or ectopic expression of Tg14-3-3 reflects specific physiological involvement of Tg14-3-3 in
enhancing DC motility, or simply the artificial induction of processes regulated by host 14-3-3
proteins.
Monocytes and macrophages as Trojan horses
Monocytes are myeloid cells that circulate in the blood and are recruited to tissues during
resting and inflammatory states, where they differentiate into macrophages and monocytederived DCs (103,104). Because of their routine trafficking from blood to tissue, monocytes have
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been keenly investigated as potential Trojan horses that could deliver T. gondii across the bloodbrain barrier and into the CNS (87).
Highlighting the potential for infected monocytes to deliver T. gondii into the CNS,
monocytes were identified as the most abundantly infected leukocyte in the blood of mice
following oral infection with T. gondii tissue cysts (29). Blood monocytes are known to separate
into two subsets: inflammatory CCR2+ Ly6Chi cells and patrolling CCR2- Ly6Clo CX3CR1hi
cells (104,105). However, the distribution of T. gondii among these two subsets was not assessed
(29). Similar to the phenotype reported upon adoptive transfer of DCs, intravenous introduction
of T. gondii-infected monocytes hastened dissemination to the brain, relative to transfer of
extracellular parasites (29). Investigations modeling monocyte extravasation with an in vitro
system using human umbilical vein endothelial cells reported that T. gondii infection inhibited
integrin-mediated adherence of monocytes to endothelium (106,107), moderately enhanced the
velocity of monocytes subsequently crawling over the endothelium (108), and had no significant
impact on monocyte transmigration through the endothelium (108). Whether these phenotypes
would apply if assessed in an endothelial system that models the highly-specialized blood-brain
barrier (109) remains untested, as does the mechanistic basis that would allow parasites to
enhance vascular crawling after blocking the prerequisite step of integrin-mediated adherence
(110). An analysis of migration across transwell membranes found that infection enhanced
migration in DCs but not human peripheral blood monocytes, suggesting that monocyte and DC
motility is differentially perturbed by T. gondii infection (111).
During in vivo infections, T. gondii parasites encounter monocytes and macrophages in
the intestinal lamina propria well before entering the blood. Monocytes and macrophages
encountered in the tissue of the lamina propria include Gr1+ Ly6Chi CCR2+ inflammatory
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monocytes recruited to the infection site (112-114) and highly abundant resident CX3CR1+
macrophages that are relatively short-lived and continuously replenished from inflammatory
monocytes recruited via CCR2 signaling (115). Once disseminated to other tissues, T. gondii also
encounters self-renewing macrophages that are not replenished from circulating monocyte
populations (116). The motility of infected macrophages has not been as extensively studied as
that of monocytes and DCs. However, one study reported that T. gondii infection inhibits the
adherence of peritoneal macrophages to integrin ligands present in extracellular matrix (117),
similar to the faulty integrin-mediated adherence of monocytes. Further supporting the potential
for infected macrophages to advance dissemination, the same study reported that peritoneal
macrophages infected in vitro and then transferred back into mice traffic to mesenteric and
cervical lymph nodes, although not as quickly as LPS-activated macrophages (117). Similar to
DCs, another study reported that T. gondii infection enhanced the migration of human monocytederived macrophages across plastic transwell membranes (111).
Neutrophils as Trojan horses
T. gondii infection elicits a massive influx of both inflammatory monocytes and
neutrophils to the intestinal lamina propria. Only the recruited inflammatory monocytes appear
critical for controlling acute toxoplasmosis (112,113). However, one study noted that 5-7 days
following oral cyst infection, parasites preferentially associated with neutrophils over
inflammatory monocytes in the intestinal lamina propria (118). Infected neutrophils retained high
rates of motility and could be captured traversing intestinal epithelium in explanted tissue
sections. Unlike the phenotypes described for DCs and monocytes, T. gondii infection did not
enhance neutrophil motility, but infected neutrophils were capable of establishing infection in
new mice upon intraperitoneal transfer (118). Notably, the observed phenotypes in this study
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occurred after the typical window in which T. gondii is first detected in the bloodstream.
Neutrophils might thus act as Trojan horses that enable T. gondii to spread to new sections of
intestinal lamina propria but seem unlikely to mediate parasite escape into the circulation.
Shortcomings of existing Trojan horse models
Several independent lines of evidence thus suggest that monocytes and DCs might act as
Trojan horses that promote T. gondii dissemination. In vitro studies have convincingly shown
that T. gondii infection alters the motility of monocytes (106-108) and DCs (95,97,98). Adoptive
transfer experiments are supportive of a role for infected monocytes and DCs in promoting in
vivo dissemination (29,95). However, adoptive transfer involves extensive in vitro manipulation
of the leukocytes which may induce artificial phenotypes. Transfer of infected cells to naïve
recipient mice also fails to capture the inflammatory state that monocyte or DC Trojan horses
would encounter during a physiological T. gondii infection. In addition, advantages in the
infectivity of parasites harbored within monocytes or DCs relative to extracellular parasites after
adoptive transfer might derive from the intracellular parasites being protected from attack by
complement or IgM defenses (30) in the blood, rather than any particular connection to
leukocyte motility. Whether leukocyte Trojan horses meaningfully contribute to T. gondii
dissemination during physiological infections thus remains unclear.
Because inflammatory monocytes (112,113) and CD11c+ DCs (119) are critical for
controlling acute toxoplasmosis, ablation of these cell types alters infection progression in many
areas besides dissemination and is thus not a tractable tool for analyzing parasite dissemination.
However, T. gondii secretes a wealth of effectors known to manipulate innate immunity and
intracellular signaling (120). If the altered motility of infected monocytes and DCs is important
for their proposed roles as Trojan horses, a more tractable approach to testing this model in vivo
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could be the identification of parasite effectors required for manipulation of leukocyte motility,
and subsequent analysis of dissemination after infection with such mutants. Tg14-3-3 is the only
T. gondii protein currently implicated in these phenotypes, and as an essential gene, not a
candidate for this approach (100). However, the DC hypermigration phenotype is influenced by
T. gondii lineage (96), suggesting that relevant effectors could be identified by genetic crosses.
Genome-wide CRISPR screening technology was also recently developed for T. gondii (101)
and could alternatively be used to screen for effectors.
Modes of leukocyte migration
Much of the interest in Trojan horse-aided dissemination was motivated by the severe
clinical consequences of toxoplasmic encephalitis. Accordingly, most studies have focused on
the ability of infected leukocytes to deliver T. gondii across the blood-brain barrier. However, the
most promising Trojan horse candidates are first encountered within the intestinal lamina propria
rather than the blood stream. The confined three-dimensional nature of tissue interstitial spaces
has recently been appreciated as enabling modes of leukocyte migration that are not possible on
endothelial vasculature (121,122). Analysis of the migration of T. gondii-infected leukocytes has
largely ignored the distinctions between leukocyte motility within tissues and on endothelial
vasculature. One study reported that the hypermigration of infected DCs is capable of mediating
migration through collagen matrices that model tissue interstitium (123). Whether this is also
true of the monocytes and macrophages frequently infected in the lamina propria (28) remains
untested.
Integrin-dependent leukocyte migration
Early studies of leukocyte motility used two-dimensional cell culture systems to establish
a detailed cascade that mediates leukocyte motility on the endothelium that lines circulatory
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vasculature (110). In this cascade, interactions between leukocyte L-selectin and endothelial Pand E-selectin and other glycosylated substrates are strengthened by shear stress (124) and
mediate capture of circulating leukocytes onto endothelial surfaces (110,125). The resultant
rolling of leukocytes is slowed and eventually arrested by engagement of activated
transmembrane integrins expressed by leukocytes with endothelial ligands including ICAM-1
and VCAM-1 (110,126,127). Integrin-mediated adherence enables leukocytes to proceed to
crawling over the endothelial vasculature, presumably to identify preferred sites for the final step
of this cascade, transendothelial migration. Transendothelial migration can occur through
transcellular and paracellular routes, and is delayed if crawling is inhibited (110).
Integrins serve two critical functions in the transendothelial migration cascade: enabling
stable leukocyte-endothelial adherence as described above, and acting as crucial force
transducers that convert retrograde actin flow into forward movement (128). In this system, force
is primarily generated by actin polymerization at the leading edge of migrating leukocytes. This
actin polymerization drives forward protrusion of the cell membrane and rearward translocation
of actin filaments via treadmilling (129). Myosin-driven contractility supports this system by
pulling the cell cortex rearwards. If these retrograde forces are coupled to the external
environment, the leading edge of the migration cell can pull the cell forward (129). This coupling
is achieved by linkage of the actin cytoskeleton to ligand-engaged integrins via the adaptor
protein talin (128). Integrin-talin linkage of the cytoskeleton to external ligands essentially
provide traction that prevents the treadmilling actin cortex from slipping backward in relation to
the adhesive substrate (129).
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Interstitial leukocyte migration
In stark contrast to the integrin-dependent motility leukocytes deploy to migrate over and
through endothelial vasculature, leukocyte migration through tissue interstitium does not require
any integrin functionality whatsoever. Although this idea was initially controversial, elegant
genetic studies in mice established the in vivo feasibility of integrin-independent migration by
showing that ablation of either the universal integrin adaptor talin or all relevant integrin
heterodimers did not cause any defects in DC interstitial migration (122). Further work
established that integrin-independent motility is not restricted to DCs by showing robust integrinindependent interstitial migration in neutrophils (130) and T cells (131).
The precise mechanisms of polarization and force generation that enable migration in the
absence of stable integrin-mediated adherence are a topic of active investigation, with a variety
of models proposed including membrane flow, polarized blebbing, and deformation-based
movement (129,132,133). In general, these models propose that adherence is only required for
migration in that it promotes prolonged interaction with a substrate. In confined threedimensional environments such as tissue interstitium, migrating cells do not passively disengage
from their substrates and thus do not require active adhesion to produce traction and convert
forces into movement (129). Intriguingly, such systems are theorized to produce migration more
efficiently than adhesive-based systems, as there is no need for migrating cells to devote
extensive energy to cycles of adhering and de-adhering to substrates (129).
The circumstances that prompt leukocytes to use integrin-independent migratory
strategies remain uncertain. Integrin-independent migration can be forced through either genetic
ablation of integrins or talin or the provision of artificial environments inhospitable to integrinmediated adhesion (134). However, all mammalian cell types except erythrocytes express
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functional integrins (135). Moreover, integrins bind a wide repertoire of ligands that are present
in essentially every tissue of the body (136). Accordingly, the extent to which leukocytes rely on
integrin-independent strategies during physiological scenarios remains unclear (134). To date,
the most conclusive evidence that leukocytes migrate in vivo without using stable adhesion is the
ability of integrin-deficient dendritic cells to migrate through interstitium at normal velocity
(122). Identification of in vivo scenarios where integrin-independent migration is exclusively or
preferentially performed would provide much more compelling evidence of the physiological
relevance of integrin-independent migration.
Leukocytes also appear capable of switching their migratory strategy to match their
physical environment. For example, in vivo wound healing studies showed that neutrophils can
switch from deformation-based migration to adhesion-based motility upon reaching the wound
transition zone (130). Dendritic cells presented with different substrates will shift their migratory
strategy to match the availability of integrin ligands; this change is rapid and does not alter
migration velocity (137). Matrix geometry was also shown to determine whether macrophages
migrating in 3-D used a deformation-based lowly-adhesive migratory mode or a proteolytic
highly-adhesive mesenchymal mode (138,139). The mechanisms controlling switching between
migratory modes in vivo remain unelucidated. Dissecting the ability of T. gondii to manipulate
leukocyte migration may provide insights into the regulation of leukocyte migratory modes.
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Aims and scope of thesis
The overarching goal of this thesis was to further understanding of T. gondii
dissemination by investigating two major mechanisms of parasite spread. The first aim was to
establish whether T. gondii possesses functional and robust alternatives to actin-dependent
gliding motility that would aid extracellular parasites in invading cells and tissues. The second
aim was to determine whether and how monocyte Trojan horse promote systemic parasite
dissemination, with particular emphasis on assessing whether monocytes are best suited to
deliver intracellular parasites to any specific host environments.
Abundant evidence suggests that T. gondii uses a parasite actin-myosin motor to power a
gliding motility process that enables both the locomotion of extracellular parasites and invasion
of host cells. At the outset of this study, provocative data generated by new tools for inducible
genetic deletions in T. gondii had suggested the possibility of motility and invasion processes
that did not require parasite actin. However, the essential and pleiotropic nature of T. gondii actin
(ACT1) complicated assessment of the consequences of inducible ACT1 deletion. This study
used live cell microscopy of parasite motile behaviors, immunofluorescence estimation of the of
ACT1 protein abundance, and inhibitors of actin polymerization to test whether the phenotypes
of inducible Δact1 parasites suggested that robust actin-independent motility or invasion
pathways exist.
T. gondii is also theorized to coopt the migration of infected leukocytes to promote
dissemination. During murine toxoplasmosis, monocytes and macrophages are commonly
infected in the blood and intestinal lamina propria, suggesting they would be well-poised to
promote T. gondii dissemination in several host compartments. Supporting this idea, a collection
of in vitro studies showed that T. gondii infection altered the motility of monocytes interacting
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with endothelial vasculature. However, the mechanisms controlling this altered motility were
unknown. In addition, whether infected monocytes could effectively traverse the specialized
endothelium that comprises the blood-brain barrier or migrate through tissue environments had
not been tested. This work used in vitro models of tissue and vascular environments to assess
whether the aberrant motility of T. gondii-infected monocytes supported efficient blood-brain
barrier traversal or interstitial tissue migration. This aim also identified monocyte signaling
pathways and a secreted parasite effector required for T. gondii to manipulate monocyte
migration in vitro, and murine models to evaluate the in vivo relevance of monocyte-aided
dissemination.
Toxoplasmosis is a common infection in humans and a serious threat to the
immunocompromised. The most severe manifestations of toxoplasmosis derive from the ability
of T. gondii parasites to systemically disseminate and invade protected host tissues such as the
central nervous system and developing fetus. This thesis work examines how T. gondii is able to
spread from an initial enteric infection nidus and invade diverse host tissues. Better
understanding the basis of T. gondii dissemination will inform efforts to control or prevent the
most severe clinical consequences of toxoplasmosis.
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Figures and legends

Figure 1.1: Early kinetics of T. gondii dissemination.
Infection is initiated upon ingestion of oocysts or tissue cysts. Cysts release sporozoites or
bradyzoites in the stomach, which enter the intestinal lumen and from there invade the lamina
propria. Parasites are initially detected in the apical end of intestinal enterocytes but rapidly
transition to primarily being located in the lamina propria. 2 hpi = 2 hours post infection, 6 hpi =
6 hours post infection.
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Chapter 2: Toxoplasma actin is required for efficient
host cell invasion
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Summary
Apicomplexan parasites actively invade host cells using a mechanism predicted to be
powered by a parasite actin-dependent myosin motor. In the model apicomplexan Toxoplasma
gondii, inducible knockout of actin, ACT1, was recently demonstrated to limit, but not
completely abolish invasion. This observation has led to the provocative suggestion that T.
gondii possesses alternative, ACT1-independent invasion pathways. Here we dissected the
residual invasive ability of Δact1 parasites. Surprisingly, we were able to detect residual ACT1
protein in inducible Δact1 parasites as long as 5 days after ACT1 deletion. We further found that
the longer Δact1 parasites were propagated after ACT1 deletion, the more severe of an invasion
defect was observed. Both findings are consistent with the quantity of residual ACT1 retained in
Δact1 parasites being responsible for their invasive ability. Furthermore, invasion by the Δact1
parasites was also sensitive to the actin polymerization inhibitor cytochalasin D. Finally, there
was no clear defect in attachment to host cells or moving junction formation by Δact1 parasites.
However, Δact1 parasites often exhibited delayed entry into host cells, suggesting a defect
specific to the penetration stage of invasion. Overall, our results support a model where residual
ACT1 protein retained in inducible Δact1 parasites facilitates their limited invasive ability, and
confirm that parasite actin is essential for efficient penetration into host cells during invasion.
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Introduction
Toxoplasma gondii is a model for studying the gliding motility and active host cell
invasion characteristic of many members of the Apicomplexa phylum of eukaryotic parasites.
During gliding, T. gondii tachyzoites secrete transmembrane adhesins at their apical (anterior)
end (32). Rearward trafficking of these adhesins is predicted to generate the force that propels
the parasite forwards (32). A parasite actin-dependent myosin motor is thought to power this
process (17,56). Under the currently prevailing model for gliding and invasion, the force
generated by gliding motility can be exploited to power movement along a surface substrate,
invasion into a host cell or across biological barriers, or egress out of a host cell (32).
When used for invasion, gliding motility is coupled to secure apical attachment to a host
cell. Once apically attached, parasites squeeze through a tight constriction referred to as the
moving junction (MJ) and penetrate into the host cell (58,63). Invasion is rapid, typically
completing in less than a minute (57), but contains several distinct stages (140). The first
committed step is apical attachment to a host cell, with contact mediated by sequential secretion
of proteins from the microneme and rhoptry organelles (62). Penetration though a MJ containing
a complex of micronemal and rhoptry neck proteins (141,142) leads to invagination of the host
cell plasma membrane. Ultimately, pinching off of the host membrane results in internalization
(32,140).
A role for parasite actin in invasion was first suggested by studies demonstrating the
ability of the actin polymerization inhibitor cytochalasin D (CytD) to block invasion (143). T.
gondii encodes only one actin gene, ACT1 (67). Subsequent studies showed CytD sensitivity is
abolished in parasites bearing a CytD-resistance conferring act1A136G allele, but unaffected by the
introduction of a CytD-resistant actin allele in host cells (17). In concert, these results were
30

interpreted to indicate that CytD acts primarily and specifically on T. gondii ACT1, and support
a role for ACT1 polymerization as necessary for invasion.
Although CytD mutant analysis suggests parasite ACT1 is the predominant actin required
for invasion, host cell actin may also contribute to invasion. In support of this idea, several recent
studies have highlighted rearrangements of host cell cortical actin during invasion, and proposed
a possible secondary role for host actin during invasion (59,60). In addition, the development of
a Cre-Lox based inducible knockout system for T. gondii facilitated the generation of inducible
ACT1 knockout parasites (68). Studies using these inducible Δact1 parasites have demonstrated
that low levels of invasion are observed as many as 4 days following ACT1f excision (68,69).
This result has been suggested as evidence for the presence of an alternative, ACT1-independent
invasion pathway in T. gondii (68,69). Under this model, it was suggested that the essential
function of ACT1 is to enable segregation of the apicoplast organelle among daughter cells (68),
rather than participate in invasion. Additionally, based on noted defects in MJ formation by these
inducible Δact1 parasites, it was proposed that any role for ACT1 in invasion occurs during early
attachment stages (69), rather than powering penetration as was previously theorized (17).
Additional studies used the same Cre-Lox technology to generate stable parasite lines
deleted for the myosin MYOA (68,69) and micronemal MJ component AMA1 (70). As T. gondii
is an obligate intracellular parasite, the viability of these knockouts clearly demonstrates that
MYOA and AMA1 are not essential for invasion, as had been previously theorized (56,144).
Further work has demonstrated that paralogs can functionally compensate for MYOA and AMA1
loss (72,73). A similar scenario is unlikely to apply to ACT1, as the T. gondii genome does not
encode any clear ACT1 paralogs. However, all studies so far agree that, unlike MYOA and
AMA1, ACT1 appears to be an essential gene in T. gondii, in that no viable null clones are able to
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grow as stable lines (68,69). Accordingly, ACT1 function can only be analyzed in parasites that
are depleted for ACT1, rather than in true phenotypic nulls. Notably, T. gondii ACT1
polymerizes isodesmically, with no apparent critical concentration required to support
polymerization (74,75). It thus is possible that even very low amounts of ACT1 retained in
inducible Δact1 parasites could be sufficient to support ACT1 polymerization. Unfortunately, to
date studies using inducible Δact1 parasites have only cursorily examined these mutants for
residual ACT1 (68,69), and failed to rigorously quantify the residual ACT1 present in these
mutants. It thus remains uncertain how closely inducible Δact1 parasites approximate true
phenotypic nulls, or whether ACT1 polymerization is likely to be entirely ablated in such
mutants.
Here we sought to analyze in more detail the invasion of inducible Δact1 parasites. In
particular, we focused on evaluating: 1) how severely and consistently ACT1 is depleted in
Δact1 parasites; 2) how robustly invasion and other forms of gliding motility are able to continue
in Δact1 parasites; and, 3) how ACT1 depletion impacts specific stages of invasion. In total, our
results highlight the importance of residual ACT1 in evaluating the phenotype of inducible Δact1
parasites, and confirm that ACT1 is specifically required at the penetration stage of invasion.
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Results
Impact of ACT1 knockout on parasite motility
To investigate the relationship between ACT1 protein abundance and function, we
assayed actin-dependent motility using an inducible knockout strain, ACT1f, described
previously (68). We compared the ability of parasites to invade host cells, egress from host cells,
and to glide on serum-coated glass 2 days after ACT1 disruption. As rapamycin induction
achieves only low rates of ACT1f excision in this strain, we analyzed the invasion competence of
Δact1 parasites by tracking their abundance in a mixed population of ACT1f intact and Δact1
parasites (YFP positive), before and after invasion of host cells. To do this, we modified a
standard immunofluorescence-based invasion assay (145) to stain parasites based on whether
they were YFP positive or negative, in addition to determining if they were intracellular or
extracellular. This modification allows for the classification of every parasite as intracellular or
extracellular based on permeabilization-selective staining, and Δact1 or ACT1f intact based on
YFP expression. When invasion was analyzed in this manner, Δact1 parasites were consistently
under-represented among intracellular parasites relative to their abundance in the input
population, indicating a strong invasion defect (Figure 2.1A). Similarly, when A23187-induced
egress was observed by time-lapse video microscopy, Δact1 vacuoles overwhelmingly failed to
egress from host cells, indicating a strong egress defect compared to ACT1f intact parasites
(Figure 2.1B). Δact1 parasites were also observed to glide less frequently on serum-coated
coverslips than ACT1f intact parasites, and although less efficient, knockouts were capable of all
three motility patterns (Figure 2.1C).
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Generation of a new inducible ACT1 knockout
The low excision rate of the ACT1f strain hinders rigorous quantification of these
mutants’ phenotypes. Accordingly, to facilitate further work with inducible Δact1 parasites, we
used the same strategy employed previously (68) to generate additional ACT1f clones. Briefly, in
this strategy the native ACT1 allele was replaced by double homologous recombination with an
exogenous copy where the ACT1 coding sequence is immediately flanked 5’ and 3’ by LoxP
sites, and followed downstream by a YFP reporter and selectable HXPGRT marker (Figure S1).
The native ACT1 promoter was retained so that Cre-mediated recombination at the LoxP sites
creates a locus where ACT1 is deleted, and YFP is instead expressed from the ACT1 promoter.
We isolated a clone, ACT1f-2, with reliably high excision (>75% rapamycin-induced excision as
indicated by YFP expression), that was used for the remainder of our studies.
Residual ACT1 in inducible knockouts
To correlate knockout phenotypes with the extent of ACT1 depletion, we developed a
semi-quantitative approach that uses ACT1 immunofluorescence staining intensity in single
parasites as a proxy for ACT1 protein abundance (Figure 2.2A). Consistent with a previous
report (69), we observed that a large portion of the Δact1 parasites retained substantial residual
ACT1 at 2 days after the induction of gene excision (Figure 2.2B-C). When assayed 3 days or
more following induction of gene excision, Δact1 parasites were much more uniformly depleted
for ACT1 relative to ACT1f intact controls (Figure 2.2B-C). Importantly, at all time-points
considered, the mean ACT1 staining intensity of Δact1 parasites never fell below the low end of
ACT1 staining observed in ACT1f intact parasites (Figure 2.2B-C). Similar low level ACT1
staining was also observed in parasites of the parental diCre strain bearing a native ACT1 locus
(Figure 2.2B-C), suggesting these results are unlikely to be an artifact of misclassifying Δact1
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parasites as ACT1f intact due to low YFP expression. In addition, in every biological replicate
and every time-point, even 5 days after inducing gene disruption, a small number of knockout
parasites still stained moderately for ACT1 (Figure 2.2B-C).
We then asked whether any of the detected residual ACT1 staining in Δact1 parasites
might actually represent bleed through from the YFP channel, or cross-reactivity of the actin
antibody. To test for bleed through, we altered our immunostaining protocol to exclude the
primary or secondary antibodies used to detect ACT1. These alterations strongly reduced the
signal observed in the ACT1 channel, suggesting that the original signal detected using TgACT1
antibody was only minimally influenced by channel bleed through (Figure S2). Replacing our
TgACT1 antibody with rabbit IgG sera as an isotype control also significantly reduced the
observed signal, although not as strongly as exclusion of primary or secondary antibodies (Figure
S2). Unlike the TgACT1 staining in Δact1 parasites, the mean signal observed using this isotype
control was below the range of TgACT1 staining observed in ACT1f intact parasites. Thus,
portion, but not all, of the residual staining with TgACT1 in Δact1 parasites may derive from a
low level of reactivity of rabbit sera against parasites. Because of the low reactivity of rabbit sera
against parasites, we further tested specificity of the residual ACT1 staining by using a
monoclonal mouse antibody raised against Dictyostelium actin. Using this monoclonal antibody,
we again observed substantial residual ACT1 staining in Δact1 parasites (Figure 2.2B), again
suggested the observed signal does indeed reflect residual ACT1 in Δact1 parasites.
The consistent presence of residual ACT1 in some portion of Δact1 parasites, combined
with the prior observation that Toxoplasma ACT1 polymerizes isodesmically with no detectable
critical concentration (74), led us to hypothesize that trace ACT1 retained by Δact1 parasites
may suffice to support the limited invasion observed after gene disruption. Under this model, we
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would predict that the longer parasites are maintained after ACT1 disruption, the more strongly
depleted of protein they would be, and the more severe defects in invasion would become. To
test this, we used our modified invasion assay to determine the severity of the invasion defect in
parasites maintained for 2-5 days after rapamycin-induction of ACT1f excision. As predicted, the
strength of Δact1 parasites’ invasion defect positively correlated with the length of time parasites
were maintained after inducing gene excision (Figure 2.3A).
If residual ACT1 is responsible for the continued ability of some Δact1 parasites to
invade host cells, we would expect that ACT1 would still be detectable in Δact1 parasites
following invasion. To test this, we quantified ACT1 immunofluorescence staining intensity in
confocal images of parasites that were allowed to newly invade fibroblasts 4 days after
rapamycin induction of ACT1f excision. In this experiment, we observed no significant
differences in the ACT1 content of intracellular or extracellular parasites, although Δact1
parasites were again on average depleted for ACT1 relative to ACT1f intact parasites (Figure
2.3B). Importantly, there was substantial overlap in the ACT1 staining intensity observed in
individual Δact1 and ACT1f parasites, again consistent with a model of residual ACT1
facilitating Δact1 parasite invasion (Figure 2.3B).
Sensitivity of invasion to actin polymerization inhibitors
Parasite invasion is known to be sensitive to the actin polymerization inhibitor
cytochalasin D (CytD) (17). If Δact1 parasites rely on residual ACT1 for invasion, we reasoned
these Δact1 invasions would retain CytD sensitivity. To test this, we used our modified invasion
assay to track parasite invasion into both HFF cells and a CytD-resistant epithelial cell line, Cyt1 (146). Four days after the induction of gene excision, we observed dose-dependent CytD
inhibition of invasion into HFFs by both ACT1f intact and Δact1 parasites, confirming invasion
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by Δact1 parasites is indeed actin-dependent (Figure 2.4A). CytD is a reversible inhibitor of
actin polymerization. Because Δact1 parasites contain less ACT than ACT1f intact parasites, we
accordingly predicted that Δact1 parasites would be inhibited at lower CytD concentrations than
ACT1f intact parasites. Consistent with this prediction, when invading HFFs, Δact1 parasites
were inhibited by 200 nM CytD in 3 independent experiments, while ACT1f intact parasites
never showed significant sensitivity below 500 nM CytD (Figure 2.4A).
We then asked if in the case of Δact1 parasite invasion, CytD sensitivity might reflect
inhibition of an actin-dependent pathway in the host. This possibility was tested by analyzing
invasion into the CytD-resistant epithelial cell line, Cyt-1 (146). For all parasites, invasion into
Cyt-1 cells was slightly more CytD sensitive than in HFF cells. This may stem from differing
quantities of actin in the host cells altering the effective CytD concentration experienced by the
parasites, or the drug impacting host processes that may contribute to invasion. Importantly,
however invasion by both Δact1 and ACT1f intact parasites into Cyt-1 cells was inhibited by
CytD (Figure 2.4). Furthermore, parallel invasions by parasites with a CytD-resistant act1A136G
allele (17), into both HFF and Cyt-1 cells was not affected at these concentrations of CytD,
supporting the ability of our assay to detect a CytD-resistant phenotype. In combination, these
results suggest that the major invasion-inhibiting target of CytD is parasite actin, rather than host
actin, for both Δact1 and ACT1f intact parasites.
Impact of ACT1 knockout on invasion stages
We finally asked if it was possible to delineate roles for ACT1 in specific stages of
invasion. We first considered the attachment of parasites to HFFs rendered too rigid to invade by
glutaraldehyde fixation. When a mixed population of ACT1f intact and Δact1 parasites were
allowed to attach to glutaraldehyde-fixed HFF, Δact1 parasites were similarly abundant among
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the input parasite population and attached parasites, indicating that ACT1 disruption does not
inhibit the initial attachment stages of invasion (Figure 2.5A). We then used a short (90 sec)
invasion pulse and staining for the MJ marker RON4 to consider whether Δact1 parasites could
effectively secrete rhoptry contents and establish a MJ. In these experiments, Δact1 parasites
were significantly less likely to have completed penetration in comparison to ACT1f intact
parasites (Figure 2.5B). Importantly, however, about half of the Δact1 parasites detected were
apically-attached at a focus of RON4 secretion, or in the process of actively penetrating a host
cell (Figure 2.5B), suggesting the failure of Δact1 parasites to invade does not reflect an inability
to establish a functional MJ.
Relatively few Δact1 parasites were detected as intracellular in comparison to the number
captured in the process of penetration in our MJ assays (Figure 2.5B). We hypothesized that this
may reflect that Δact1 parasites may either penetrate more slowly than ACT1f intact parasites, or
fail to complete invasion attempts at all. To test this possibility, we used time-lapse video
microscopy to observe invasions by ACT1f intact and Δact1 parasites. About half of the Δact1
parasite invasions detected were completed in a similar time frame as ACT1f intact parasite
invasions (Figure 2.5C). The detection of some Δact1 invasions with normal kinetics are
consistent with a model where a portion of the Δact1 parasites are not strongly depleted for
ACT1 and thus are not true phenotypic nulls. However, while nearly all ACT1f intact parasite
invasions were complete within a minute, almost a third of the Δact1 parasite invasions failed to
complete within 4 minutes (Figure 2.5C), suggesting that Δact1 parasites have a specific defect
in the penetration stage of invasion.
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Discussion
Here we sought to evaluate if limited invasion by inducible Δact1 parasites supports a
need for revising the current model that invasion requires a parasite actin-dependent myosin
motor. Our analysis of invasion, gliding motility, and egress all indicated that gliding motilitydependent behaviors are inhibited, but not completely abolished, in Δact1 parasites 2 days
following ACT1f excision (Figure 2.1). By quantifying ACT1 abundance in individual parasites,
we found that residual ACT1 is detectable in Δact1 parasites as many as 5 days after inducing
ACT1f excision (Figure 2.2). Supporting functional relevance of this residual ACT1, we observed
a positive correlation between the length of time Δact1 parasites are propagated after ACT1f
excision and the severity of the invasion defect observed in Δact1 parasites. Consistent with a
model where residual ACT1 enables Δact1 parasite invasion, both ACT1f and Δact1 parasites
were sensitive to the actin polymerization inhibitor CytD (Figure 2.4). We were unable to detect
a defect in host cell attachment for Δact1 parasites (Figure 2.5A). We further found that Δact1
parasites were capable of secreting rhoptries and forming functional MJs (Figure 2.5B).
However, the frequent failure of Δact1 parasites to complete invasion attempts within the time
period typical for wild-type parasites (Figure 2.5C) suggests a requirement for ACT1f specific to
the penetration stage of invasion.
Initial studies using inducible Δact1 parasites observed low levels of parasite motility and
invasion as many as 4 days after ACT1f excision, and interpreted the ability of some parasites to
still invade as evidence in support of an ACT1-independent invasion pathway in T. gondii
(68,69). In these studies, the conclusion that ACT1 polymerization was ablated in inducible
Δact1 parasites relied on qualitative estimation of residual ACT1 by immunofluorescence
staining, and Western blots of pooled parasite extracts, although the sensitivity of this method
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was not determined (68,69). In contrast, our quantification of ACT1 content in individual
parasites revealed that there is considerable overlap in the ACT1 content of individual Δact1 and
ACT1f intact parasites, even 5 days after ACT1f excision (Figure 2.2). We were surprised to
detect Δact1 parasites with moderate levels of ACT1 so long after rapamycin-induction of ACT1f
excision. We speculate that these cases represent either parasites that spontaneously excised
ACT1f after rapamycin induction, or parasites that inherited an unusually large portion of the
ACT1 mRNA or protein present at the time of ACT1f excision. Both scenarios are likely rare.
However, the fitness defects associated with substantial ACT1 depletion could easily impose a
strong selection in favor of any rare Δact1 parasites with significant residual ACT1 and thus
increase their prevalence in the population.
Our subsequent finding that extended propagation of Δact1 parasites is correlated with
increased severity of the invasion defect supports the role of actin in this process. Accordingly,
the isodesmic polymerization of ACT1 (74) should allow low amounts of residual ACT1 to form
filaments and power invasion. We note that the increasing severity in invasion defect was
moderate relative to the expected rapid dilution of ACT1 protein among dividing Δact1
parasites. However, quantification of ACT1 levels in Δact1 parasites by IFA also did not show
Δact1 parasites becoming dramatically more depleted for ACT1 beyond day 3. We hypothesize
that upon falling below some required threshold for ACT1 content, Δact1 parasites perish and
are thus removed from the population.
Further support for the residual ACT1 model is provided by the finding that invasion by
inducible Δact1 parasites retained sensitivity to the actin polymerization inhibitor, CytD. The
inability of CytD-resistant host cells to rescue invasion by Δact1 parasites demonstrates that
CytD is not inhibiting invasion by acting on a host actin-dependent pathway. Rather, CytD
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inhibits the invasion of Δact1 parasites by acting on a parasite target, presumably ACT1, which
exhibits CytD-sensitive filament assembly in vitro (75). We cannot, however, exclude the
possibility that CytD might target some other protein in Δact1 parasites, such as the previouslydescribed actin-like proteins encoded by T. gondii (147).
When considering the invasion stages that ACT1 depletion may impact, we did not detect
a defect in the attachment of Δact1 parasites to glutaraldehyde-fixed host cells. After attaching to
host cells, invading parasites go on to secrete rhoptry proteins and penetrate through a MJ (58).
A previous study reported that Δact1 parasites overwhelmingly fail to secrete rhoptries or form
MJs, and hypothesized this MJ formation defect is primarily responsible for the failure of Δact1
parasites to invade host cells (69). When we analyzed MJ formation, we also found that Δact1
parasites were less efficient at invasion. However, we observed that nearly half of the Δact1
parasites attached to host cells had already secreted rhoptries, or even begun penetrating into the
host cell (Figure 2.5B). Our results suggest that many Δact1 parasites are able to form functional
MJs, but are inhibited at a later step in the invasion process. The discrepancy in these results may
stem from methodological differences between the studies. Specifically, our assay used a much
shorter invasion pulse (90 sec vs. 5 min), designed to capture a greater number of parasites still
in the process of invading (~2-fold more). However, given the discrepancy between these results
and their respective interpretations, we wished to further probe the potential defect of Δact1
parasites in invasion stages following attachment and MJ formation. Our subsequent finding that
Δact1 parasites often fail to complete invasion within the time period typical for ACT1f intact
parasites, as determined by video microscopy, serves as further evidence that Δact1 parasites
have a defect specific to the penetration stage of invasion.
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In concert, our results are consistent with a model where ACT1 is essential for efficient
penetration of T. gondii into host cells. Under this model, inducible knockout of ACT1 leads to
depletion of ACT1 protein and corresponding defects in invasion and other gliding motilitydependent processes. However, because ACT1 deletion is ultimately lethal to T. gondii,
generating populations of Δact1 parasites that are true phenotypic nulls is not feasible. Instead,
Δact1 parasite populations generated by Cre-mediated excision of ACT1f contain parasites, that
although Δact1 by genotype, still retain functionally-relevant quantities of ACT1. Because these
parasites with residual ACT1 are present in Δact1 parasite populations, invasion is able to
continue, albeit at a reduced level. Notably, our results do not exclude the possible existence of
additional pathways that could contribute to T. gondii invasion. However, the existence of such
alternative pathways is not necessary to explain the phenotype of Δact1 parasites. Moreover, any
such alternative pathways seem unlikely to be major contributors to T. gondii invasion, as they
are not able to offer a robust or efficient alternative to ACT1-dependent invasion, as evidenced
by the major invasion defects of Δact1 parasites.
The development of inducible Cre-Lox genetic tools for T. gondii (68) offers an exciting
opportunity to dissect essential processes. In particular, inducible Cre-Lox technology has
facilitated the deletion of several genes thought to encode essential components of the invasion
machinery (68-70). For some of these genes, residual invasive ability can be explained by
functional redundancies built in the T. gondii genome (72,73). For other truly essential genes
such as actin, our results highlight the importance of considering the functional implications of
residual protein retained in mutants after inducible gene knockout.
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Materials and methods
Parasite strains and growth conditions.
Parasites were passaged as tachyzoites in human foreskin fibroblast (HFF) monolayers as
previously described (57). An RH Δku80::diCre strain (68), here referred to as diCre, was used
as a wild-type control strain, and to generate the new inducible ACT1 knockout. Initial
experiments used a previously described inducible ACT1 knockout, diCre-Act1 (68), here
referred to as ACT1f-1. Subsequent experiments used a new inducible ACT1 knockout, ACT1f-2,
created as described below. In both ACT1f strains, excision was induced by treating partially
lysed (50-75%) parasite cultures with 50 nM rapamycin for 4 hr. Induced parasites were isolated
by filtration through 3.0 micron filters (Nucleopore), washed twice by dilution in HHE (Hank’s
Balanced Salt Solution supplemented with 1M HEPES and 0.1M EGTA) and centrifugation at
400 x g to remove any residual rapamycin, and then used to infect fresh HFF monolayers. Mixed
populations of ACT1f intact and Δact1 parasites were isolated by mechanical lysis of partially
lysed cultures, typically 40-48 hours after inoculation. To culture Δact1 parasites for 4-5 days,
cultures were mechanically lysed 2 days after induction and re-infected into HFFs at high doses
to compensate for low invasion.
Generation of new inducible ACT1 knockout strain
Plasmids and oligonucleotides used in this study are listed in Table 2.1. To generate the
high-excising ACT1f-2 strain, a plasmid (pLD-03) was constructed with the ACT1 CDS
immediately flanked 5’ by a Toxoplasma-specific Kozak sequence (GGCAAA) and LoxP site,
and 3’ by a LoxP site followed by a YFP reporter and the HXPGRT selectable marker. To this
end, the LoxP-flanked 3’UTR of ACT1 was amplified from RH genomic DNA and ligated into
the plasmid pG265, generating the plasmid pLD-02. Gibson assembly of the ACT1 3’UTR
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preceded by YFP and HXPGRT, isolated from pLD-02 by PacI and ApaI digestion, and ACT1
5’UTR and CDS fragments amplified from genomic DNA was then used to generate pLD-03.
The resulting ACT1-floxing cassette was then released from pLD-03 by PvuII digestion to
expose the 5’ and 3’ ends of the construct for homologous recombination, and electroporated
into the diCre strain. After selection with 25 µg/mL mycophenolic acid and 50 µg/mL xanthine
(Sigma-Aldrich, St. Louis, MO), parasite clones were isolated by limiting dilution in 96-well
plates containing HFF monolayers. Clones were screened with both diagnostic PCR (Figure S1)
and dual ACT1/YFP immunostaining after rapamycin treatment to obtain ACT1f-2, a reliably
high-excising inducible knockout strain.
Invasion assay
A previously developed differential staining method was adapted to identify parasites as
intracellular or extracellular, and ACT1f intact or Δact1 (148). In this assay, parasites harvested
by mechanical lysis were allowed to invade sub-confluent HFF monolayers on coverslips for 30
min. After thorough rinsing, coverslips were first stained with mAb DG52 to SAG1 to mark
extracellular parasites. Cell were then permeabilized with 0.05% saponin. After
permeabilization, rabbit anti-TgACT1 (67) and rat anti-GFP (Santa Cruz Biotechnology) were
used to identify Δact1 parasites by YFP expression. All primary antibodies were recognized by
fluorophore-conjugated secondary antibodies (DG52: Alexa594; TgACT1: Alexa647; GFP:
Oregon Green 488). Slides were imaged on a Cytation3 cell imaging multimode reader, using
Gen5 software for analysis (BioTek, Winooski, VT). All experiments were performed at least 3
independent times, each with 3-5 technical replicates.
To determine the abundance of Δact1 parasites in input populations, aliquots of the
parasites used for invasion were adhered to poly-L-lysine-coated coverslips, and then stained
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with mouse anti-GFP and rabbit anti-TgACT1, followed by fluorophore-conjugated secondary
antibodies (GFP: Alexa594; TgACT1: Alexa488). Slides were visualized on a Zeiss Axioskop 2
MOT Plus microscope with an AxioCam MRm monochrome camera and Axiovision software
(Carl Zeiss, Inc., Thornwood, NJ).
To test the effect of cytochalasin D (CytD) on invasion, parasites were allowed to invade
both CytD-sensitive HFF host cells, and CytD-resistant Cyt-1 (24) host cells. HFF cells were
seeded onto 96-well plates, and Cyt-1 cells on 0.1% gelatin-coated coverslips. Prior to invasion,
cells were pre-treated for 10 min at room temperature with either CytD or 0.02% DMSO. In
experiments testing invasion into HFF cells, only parasites were pre-treated with CytD; when
testing invasion into the resistant Cyt-1 cells, both parasites and the Cyt-1 cells were pre-treated
with CytD. After CytD pre-treatment parasites were briefly settled onto host cells by
centrifugation at 400 g and 18°C for 2 min, and then allowed to invade for 12 min at 37°C. The
same differential staining approach described above was used, except that Cyt-1 cells were
permeabilized with 0.25% Triton X-100.
Time-lapse microscopy of egress, gliding, and invasion
To observe egress, parasites were infected onto HFF monolayers on glass-bottom culture
dishes (MatTek, Ashland, MA), and cultured for 2 days. Immediately prior to the experiment,
monolayers were rinsed twice into Ringer’s media (155 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1
mM MgCl2, 3 mM NaPO4, 10 mM HEPES, 10 mM D-glucose, pH 7.4). To induce egress, 2 µM
A23187 was added 30 sec into 10 min total acquisition periods, during which alternating
brightfield and FITC fluorescence images were captured at ~2 frame/5 sec, using the Zeiss Axio
Observer Z1 imaging system and Zen software as previously described (149).
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Gliding motility was observed with video microscopy as previously described (50),
expect that dishes were pre-coated with 50% fetal bovine serum. Alternating brightfield and
FITC fluorescence images were acquired at ~1 frame/3 sec. Data from multiple videos taken on
the same day were pooled so that 25 -60 Δact1 parasites were analyzed for every experiment,
with ACT1f intact parasites from the same videos serving as control.
Invasion was monitored with video microscopy as previously described (149), expect that
cells were imaged in dishes containing indicator-free DMEM (Sigma D5030) supplemented with
1g/L glucose, 25 mM HEPES, and 3% FBS (pH 7.4). Alternating brightfield and FITC
fluorescence images were acquired for 10 min periods at ~3 frame/ sec. Invasion duration was
defined as the length of times parasites displayed visible moving junctions. To analyze the rare
Δact1 invasion events, data from 16 independent experiments were pooled, and randomly
selected invasions by ACT1f intact parasites from the same days used as control.
Quantification of ACT1 abundance by IFA
ACT1 staining intensity was used as a semi-quantitative proxy for ACT1 protein
abundance. Parasite-infected HFF monolayers were fixed with 4% formaldehyde, and subjected
to permeabilization with 0.05% Saponin and immunostaining. When considering only ACT1 and
YFP expression, ACT1 was stained with rabbit anti-TgACT1 and YFP with mouse anti-GFP,
followed by fluorophore conjugated secondary antibodies (TgACT1: Alexa594; YFP:
Alexa488). For these experiments, 0.25 micron Z-series of images were acquired on a Zeiss
Axioskop 2MOT Plus microscope, and deconvolved with a nearest-neighbor algorithm in
AxioVision software. When distinguishing intracellular and extracellular parasites in addition to
ACT1 and YFP expression, cells were stained with the GFP/TgACT1/DG52 antibody
combinations used in the modified invasion assay. For these experiments, images were acquired
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on a Zeiss LSM 510 META Confocal Laser Scanning Microscope and LSM Image Examiner
software. In all experiments, at least 20 parasites for every reported category were measured. To
quantify ACT1 staining in images generated by either method, individual parasites were
manually traced and fluorescent signals were quantified using Volocity software (Perkin Elmer,
Waltham, MA). The mean signal of 5 host cytosol regions within the same field of view was
used for background subtraction.
Attachment assay
Confluent HFF monolayers in 96-well plates were fixed for 10 min in 2% glutareldehyde
to generate rigid, impenetrable host cells. Once fixed, HFF were rinsed in PBS and quenched
overnight in 1M glycine. The day of the assay, the fixed HFF were rinsed in D3 (DMEM
supplemented with 3% FBS, 2 mM glutamine, 10 µg/mL gentamicin, 44 mM sodium
bicarbonate, and 10 mM HEPES), and then equilibrated at least 1 hour in D3 at 37°C, and
transferred to Invasion Media (DMEM supplemented with 3% FBS and 25 mM HEPES)
immediately before the assay. After briefly settling parasites into each well with 2 min of
centrifugation at 400 g, attachment was carried out for 15 min at 37°C. Unattached parasites
were then removed by rinsing wells 10 times with room temperature PBS. Live parasites
attached to the glutareldehyde-fixed HFF were immediately imaged, using the Zeiss Axio
Observer Z1 imaging system with Zen software (Carl Zeiss, Inc., Thornwood, NY) and an
ORCA-ER digital camera (Hamamatsu Photonics, Japan) to generate brightfield and FITC
images. 80-200 parasites, split among at least 2 separate fields of view were analyzed for each
well. Brightfield and FITC images of control aliquots of parasites spun directly into HFF-free
wells were used to determine the abundance of YFP-expressing Δact1 parasites in the input
population.
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Moving junction assay
After harvesting by mechanical lysis, parasites were transferred to intracellular buffer (5
mM NaCl, 142 mM KCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM D-glucose, 25 mM HEPES, pH
7.4), and allowed to invade sub-confluent HFF monolayers on coverslips in 24-well plates for 90
sec. The 24-well plates were then immediately transferred to an ice water bath. Coverslips were
rinsed, then fixed with 4% formaldehyde, and processed for immunofluorescence. To mark
extracellular parasites, cells were stained with mAb DG52 prior to permeabilization with 0.05%
Saponin. After permeabilization, anti-GFP was used to mark Δact1 parasites, a rabbit polyclonal
antibody to RON4 provided by John Boothroyd used to mark the moving junction, and
fluorophore-conjugated secondary antibodies (DG52: Alexa350; GFP: Alexa488; RON4:
Alexa594) were used for visualization. Images were acquired on a Zeiss Axioskop 2MOT Plus
microscope, using an AxioCam MRm monochrome camera and Axiovision software (Carl Zeiss,
Inc., Thornwood, NY).
Statistics
All statistical tests were performed in Prism (Graph-Pad Software, Inc., La Jolla, CA).
Unless otherwise noted, data sets were assumed to be normally distributed and analyzed with
repeated measures one-way ANOVA if considering only a single independent variable (e.g.
genotype alone), and two-way ANOVA if considering two independent variables (e.g. genotype
and CytD). To compare individual means within an ANOVA, Dunnett’s multiple comparisons
test was used if comparing all means against a single control, and Sidak’s multiple comparisons
test if comparing selected pairs of means. ACT1 staining intensity data sets were not normally
distributed and accordingly analyzed using a non-parametric Kruskal-Wallis test, and Dunn’s
multiple comparisons test for selected groups. To accommodate non-complete invasion events,
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invasion duration data was treated as ordinal and analyzed with a Mann-Whitney test. All post
tests used corrections for multiple comparisons. In all cases two-tailed P –values were
calculated, and P ≤ 0.05 was considered significant.
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Figures, tables and legends

Figure 2.1: Analysis of actin-dependent motility after deletion of ACT1f.
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(A) Invasion efficiency determined with a differential staining protocol that detects intracellular
or extracellular parasites based on protection from SAG1 (mAb DG52) staining prior to
permeabilization, and differentiates between ACT1f intact and Δact1 based on YFP expression.
Percentage of knockouts in the input parasite population, intracellular, or extracellular parasites
after a 30 min invasion period is shown as mean +/- SD (N=3). **, P ≤ 0.01, one-way ANOVA
with Dunnett’s multiple comparisons test. Data shows 1 of 3 independent experiments, in all of
which Δact1 parasites were significantly under-represented among intracellular parasites relative
to the input. (B) Egress induced by A23187 and tracked with time-lapse video microscopy.
Δact1 parasites were identified by YFP expression. Traces show cumulative percent egression of
N ≥ 16 vacuoles; each individual trace represents an independent experiment. (C) Parasite
gliding on serum-coated coverslips as observed by time-lapse video microscopy; Δact1
determined by YFP expression. Columns show mean percentages of parasites +/- SD, from 3
independent experiments, each with 25-60 Δact1 parasites scored. *, P ≤ 0.05, one-way
ANOVA. All experiments were performed 2 days after rapamycin induced excision of ACT1f in
a previously described strain (15), ACT1f-1.
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Figure 2.2: Estimating ACT1 abundance after gene excision.
(A) ACT1 abundance was estimated by immunofluorescence staining intensity. Individual
parasites were traced in de-convolved Z-series images to quantify anti-TgACT1 staining
intensity. Δact1 parasites were identified by YFP expression, as indicated by anti-GFP staining.
The mean signal from 5 host cytosol regions within the same field of view was used for
background subtraction. Images depict an example field containing both ACT1f and Δact1
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parasites, 4 days after inducing gene excision. Scale bar = 5 microns. (B-C) Quantification of
ACT1 staining intensity in ACT1f-2, and the parental diCre strain, 2-5 days after rapamycin
induction of ACT1f excision. ACT1 was stained with either monoclonal anti-Dictyostelium actin
(B), or polyclonal anti-TgACT1 (C). Three separate cultures were induced in parallel, different
color intensities denote parasites from different biological replicates. Markers indicate
background-subtracted fluorescence intensities from single parasites, expressed in arbitrary units
(AU). Lines show mean intensity. **, P ≤0.01, ****, P ≤0.0001, Kruskal Wallis test with
Dunn’s multiple comparisons test. All experiments were performed with a newly-derived
inducible ACT1 knockout, ACT1f-2.
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Figure 2.3: Residual ACT1 levels and invasion by Δact1 parasites.
(A) Magnitude of the invasion defect of Δact1 parasites was determined at different time points
after rapamycin-induced ACT1 excision. Invasion defect was quantified by comparing the
frequency of Δact1 parasites among intracellular parasites after a 30 min invasion, to abundance
in the initial parasite population. Fold invasion defect = (%Δact1 in input) / (%Δact1 in
intracellular parasites). Δact1 parasite frequency was determined using the differential staining
protocol described in Figure 1. Data shows 3 independent experiments, each with 3-4 technical
replicates. Matched color shades denote technical replicates from the same experiment. Linear
regression (R2= 0.5377, P < 0.0001 different from slope = 0). (B) At 4 days after inducing gene
excision, ACT1 abundance in recently-invaded parasites was estimated by staining intensity.
Parasites were classified as intracellular or extracellular, and ACT1f intact or Δact1 using the
differential staining protocol described in Figure 2.1. Lines show mean intensity for each
category. Because invading Δact1 parasites are relatively rare, data from 3 independent
experiments were combined to generate the graph. Intensities from each data set were
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normalized to the mean intensity of ACT1f intact intracellular parasites. Matched color shading
indicates data from the same experiment. At least 20 parasites are shown for every category in
each experiment. ****, P ≤ 0.0001, Kruskal Wallis test with Dunn’s multiple comparisons test.
All experiments were performed with ACT1f-2.
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Figure 2.4: Testing sensitivity of invasion to actin inhibitor cytochalasin D.
(A-B) Parasites were classified as intracellular or extracellular, and ACT1f intact or Δact1 using
the differential staining protocol described in Figure 1. The invasion rates of ACT1f intact and
Δact1 parasites, and Cytochalasin D (CytD)- resistant act1A136 parasites were compared in CytDsensitive HFF cells (A), and Cyt-D resistant Cyt-1 cells (B). Data shows mean values, +/- SEM,
from 3 independent experiments with the ACT1f parasites and 2 independent experiments with
the act1A136 parasites, each with 3-5 technical replicates. For each group, the number of
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intracellular parasites was normalized to the mean invasion rate of that group with no CytD.
****, P ≤ 0.0001, Two-way ANOVA with Dunnett’s multiple comparisons test. All experiments
were performed with ACT1f-2, 4 days after rapamycin induction of gene excision.
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Figure 2.5: Impact of ACT1 deletion on adhesion and invasion efficiency.
(A) Efficiency of attachment to glutareldehyde-fixed HFF cells by Δact1 parasites relative to
ACT1f intact parasites was determined 4 days after rapamycin-induced ACT1 excision. Δact1
parasites were identified by YFP expression, and an aliquot of the input parasites used to
determine Δact1 parasite abundance prior to attachment. n.s., P > 0.05, unpaired T-test. Data
from one of 3 independent experiments, each with 3-4 technical replicates, is shown. In all 3
experiments no significant differences in Δact1 frequency between input and adhered parasites
were observed. (B) Moving junction (MJ) formation was analyzed by immunostaining after a 90
sec invasion pulse. Parasites were classified as: “peripherally attached” or “apically attached”
based on detection of secreted RON4; “penetrating” based on partial SAG1 (mAb DG52)
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protection and presence of RON4 rings; and “intracellular” based on protection from SAG1
(mAbDG52) staining preceding permeabilization. Images show representative Δact1 parasites
from each category. White asterisks indicate apical end. White arrowhead indicates the MJ. Scale
bars = 2 micron. Data shows means +/- SEM from 3 independent experiments, each with 3
technical replicates. **, P ≤ 0.01, two-way ANOVA with Sidak’s multiple comparisons test.
(C) Speed of invasion was determined with time-lapse video microscopy 4 days after ACT1
excision, using YFP expression to classify parasites as Δact1. Each marker represents a single
invasion event. Data from 16 independent experiments were pooled. ***, P ≤ 0.001, MannWhitney test. All experiments were performed with ACT1f-2, 4 days after rapamycin induction
of gene excision.
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Figure S1: Generation of an inducible ACT1 knockout with increased excision efficiency.
(A) Schematic of the strategy used to generate a floxed ACT1f inducible knockout. (B)
Diagnostic PCR of ACT1 locus in the diCre background used for mutant generation, and the
ACT1f-2 mutant prior to, and 4 and 48 hours following induction of gene excision with
rapamycin. PCR-1 analyzes 5’ integration of the floxing construct, and also detects Cre-mediated
excision. PCR-2 analyzes 3’ integration of the floxing construct.
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Figure S2: Specificity of ACT1 staining.
ACT1f-2 parasites were stained with the indicated antibody combinations 4 days after inducing
ACT1 excision with rapamycin. Rabbit IgG sera (Santa Cruz Biotechnology) was used as an
isotype control. Δact1 parasites were identified by YFP expression, and staining was quantified
as in Fig. 2. Three separate cultures were induced in parallel, different colors denote parasites
from different replicates. Markers indicate background-subtracted fluorescence intensities from
single parasites, expressed in arbitrary units (AU). Lines show mean intensity. *, P ≤0.05, **, P
≤0.01, ****, P ≤0.0001, Kruskal Wallis test with Dunn’s multiple comparisons test.
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Table 2.1: Primers and oligonucleotides used in this study.
Primer
LDO003
LDO004
LDO013
LDO006

Sequence
TCACCgagctcGCAGTTTGTGGTGTTTT
ATCGA
TCACCgagctcCATACCTGACCTCGCTG
AAA
ACTCACTATAGGGCGAATTGGGTAC
CGCTGCAGTTCGTGAACGAT
tttgccataacttcgtataatgtatgctatacgaagttatCTT
ACCTATGAAAAAGTGGA

Purpose
Clone 3’UTR of TgACT1 with SacI
site

LDO007
LDO012

gtatagcatacattatacgaagttatggcaaaATGGCG
GATGAAGAAGTGC
TTTATAACTTCGTATAATGTATGCTA
TACGAAGTTATTAATTTAGAAGCAC
TTGCGGTGG
AGAAGATGGTGCGCTCCTG

Clone CDS of TgACT1 with LoxP,
Kozak, and overlap for Gibson
assembly

LDO016
LDO019
LDO017
LDO020

GTACCTACGAATCGGCAATACA

Clone 5’UTR of TgACT1 with
LoxP, Kozak, and overlap for
Gibson assembly

Diagnostic PCR-1 (5’ integration of
ACT1 floxing cassette and Cremediated excision)

Diagnostic PCR-2 (3’ integration of
ACT1 floxing cassette)

TCGTTGGTTGCTGCTACGAC
GTGCAAAGCTTCTCGTACAGTG

Plasmid Construction
pLD-02 pG265-ACT3’UTR: 3’UTR of TgACT1
cloned upstream of YFP-HXPGRT
cassettes in pG265
pLD-03 pACT1iKO: 5’UTR and CDS of TgACT1
with LoxP sites inserted upstream of
TgACT1 3’UTR in pLD-02 by Gibson
assembly
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Purpose
Intermediate cloning plasmid to
generate ACT1 floxing construct
Floxing TgACT1

Chapter 3: The secreted kinase ROP17 promotes
Toxoplasma gondii dissemination by hijacking
monocyte tissue migration
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Summary
The protozoan parasite Toxoplasma gondii is thought to exploit extravasation of infected
monocytes to facilitate dissemination across endothelial barriers such as the blood-brain barrier.
Here we analyzed the migration of parasitized monocytes in models of vascular and tissue
environments. We report that infection enhanced monocyte locomotion on the surface of
endothelial cells, but profoundly inhibited monocyte transmigration across endothelial barriers.
In contrast, infection robustly increased monocyte migration through collagen-rich tissues in a
Rho/ROCK-dependent manner consistent with integrin-independent interstitial migration. We
further demonstrated that the secreted T. gondii kinase ROP17 was required for enhanced
monocyte tissue migration. In vivo, ROP17-deficient parasites failed to upregulate monocyte
tissue migration and exhibited an early dissemination delay, leading to prolonged mouse
survival. Our findings indicate that parasitized monocytes are ill-suited for delivering parasites
across the blood-brain barrier as previously predicted, but instead function to shuttle T. gondii
through tissues and thereby promote systemic dissemination.
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Introduction
The protozoan parasite Toxoplasma gondii causes severe disease in immunocompromised
humans (7). T. gondii is among the few pathogens that can cross endothelial barriers to reach
deep tissues such as the central nervous system (CNS). The parasite is theorized to hijack
leukocytes as shuttles to enable extravasation across the blood-brain barrier (BBB) (33,150).
Infected leukocytes could potentially aid dissemination at several different stages of infection.
Following oral ingestion, parasites traverse intestinal epithelium and enter the intestinal lamina
propria (15,151). Here, parasites encounter resident macrophages and dendritic cells (DCs)
(28,150,152) and trigger an influx of inflammatory monocytes (112). From this infection nidus,
parasites disseminate to draining lymph nodes, the blood, spleen, and eventually, all organs
including the brain (15,30,151). Infected leukocytes could potentially promote dissemination by
carrying parasites out of the intestinal lamina propria, through the lymphatic vasculature and into
the circulation. Circulating leukocytes could also deliver parasites across endothelial barriers and
into new tissues though the process of extravasation, a sequential cascade that is initiated by
selectin-mediated capture of rolling leukocytes, then progresses to stable integrin-based adhesion
and vascular crawling, and finally commences with endothelial traversal (110).
One of the most severe complications of toxoplasmosis is encephalitis (7). Hence, the
potential for extravasating leukocytes to ferry parasites across the BBB has been keenly
investigated (29,30). Studies aimed at mimicking this process in vitro reveal that T. gondii
infection enhanced crawling of primary human monocytes on human umbilical endothelial cells
(HUVEC), without significantly altering transendothelial migration (TEM) (108,111). These
findings led to the proposal that infected monocytes are poised to deliver T. gondii across the
BBB (87,150). However, infection diminished integrin-mediated endothelial adherence
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(106,107), a step generally considered a prerequisite to endothelial crawling and transmigration
(110). Although T. gondii infection has been shown to induce a hypermigratory state in DCs
(96,97,153,154), previous studies found that nearly all parasitized leukocytes present in the blood
of infected monocytes are CD11b+ monocytes (29). Consistent with a role for monocytes in
dissemination, adoptive transfer of infected monocytes hastens dissemination to the CNS in mice
(29). A different conclusion was reached by a recent study probing the potential for extracellular
parasites present in the blood of infected mice to seed brain infections, which noted that
adoptively transferred infected monocytes were readily detected in brain vasculature but not the
parenchyma (30). In total, current data is inconsistent with a simple model where infected
monocytes are the primary vehicle for parasites to cross the BBB.
Here we examine how infected monocytes migrate using in vitro models that mimic
vascular vs. tissue environments. We found that infection inhibited monocyte transmigration
across the BBB and peripheral endothelium, processes that require integrin-dependent adhesion.
In contrast, infection enhanced monocyte migration through collagen-rich tissues, a distinct
environment that also supports integrin-independent motility. The tissue migration of parasitized
monocytes relied upon host Rho/ROCK signaling, and the secreted parasite kinase ROP17,
which was required for efficient dissemination in vivo. Our findings suggest that T. gondii is
unlikely to cross the BBB within monocytes serving as Trojan horses, but instead rapidly spreads
within tissues to achieve systemic dissemination through activation of Rho-dependent interstitial
tissue migration in infected monocytes.
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Results
T. gondii infection impaired monocyte endothelial adherence and transmigration
We used hCMEC/D3 brain endothelial cells cultured on collagen-coated transwell inserts
(155) to model transendothelial migration (TEM) across the BBB. Uninfected THP-1 monocytes
exhibited time-dependent TEM across hCMEC/D3 monolayers, as well as enhanced migration in
response to a chemotactic gradient of MCP-1 (Figure 3.1a). Strikingly, T. gondii pre-infection
inhibited spontaneous and chemotaxis-driven TEM through hCMEC/D3 monolayers (Figure
3.1a). We extended these studies to primary monocytes from healthy human platelet donors.
TEM of primary monocytes was inhibited by prior infection with T. gondii, at different time
points (1 vs 4 h) and infection densities (MOI 1.5 vs 4) (Figure 3.1b). We further established that
T. gondii-inhibition of TEM was observed with primary and immortalized endothelial cells
derived from multiple tissue types, a hCMEC/D3-astrocyte co-culture BBB model, and parasite
strains representing all major North American T. gondii lineages and a highly genetically
divergent South American isolate (Supplementary Figure 3.1). Notably, the very low basal
migration of monocytes through human umbilical vein endothelial cells (Supplementary Figure
3.1a) likely explains the failure of an earlier study to detect significant T. gondii-induced
inhibition of TEM (108).
We hypothesized that the failure of parasitized monocytes to transmigrate may stem from
defects in integrin-mediated adherence. To test this, we measured monocyte adherence to
hCMEC/D3 monolayers. As expected, we found that pre-activation of the hCMEC/D3 with the
inflammatory cytokines TNFα and IFNγ enhanced THP-1 monocyte adherence (Figure 3.1c). In
contrast, infection with T. gondii markedly inhibited THP-1 monocyte adherence to both the
resting and cytokine-activated hCMEC/D3 model BBB (Figure 3.1c). We next asked whether
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this inhibition derived from defects in integrin-mediated adherence, through either affinity- or
avidity-enhancing processes (156). We used total internal reflection fluorescence (TIRF)
immunofluorescence microscopy to assess avidity-enhancing integrin mobilization in THP-1
monocytes adhering to fibronectin ligands. TIRF imaging revealed that T. gondii-infected
monocytes fail to spread on fibronectin surfaces, forming both significantly smaller surface
footprints and fewer detectable foci of the integrins LFA-1 and VLA-4 than mock-infected
control monocytes (Figure 3.1d-h). We further used flow cytometry to establish that T. gondii
infection did not alter surface expression of the integrins LFA-1 and VLA-4 in THP-1 monocytes
or MnCl2-induced integrin unfolding into high affinity conformations (Supplementary Figure
3.2). Collectively, these results suggest that defects in avidity-enhancing integrin mobilization
likely lead to inefficient adherence of T. gondii-infected monocytes to our model BBB resulting
in their subsequent failure to transmigrate through the endothelium.
Parasitized monocytes locomoted over BBB endothelium with an amoeboid morphology
We next asked if, despite their defects in integrin-mediated adherence, infected
monocytes could effectively crawl on model BBB, as has been reported with HUVEC (108). To
analyze migration, we cultured hCMEC/D3 cells on a soft polyacrylamide substrate previously
demonstrated to enhance endothelial maturation (157), and observed the locomotion of THP-1
monocytes expressing the actin polymerization reporter F-tractin-eGFP with video microscopy
(158). We found that infection with T. gondii enhanced THP-1 migration velocity and
displacement across hCMEC/D3 cells (Figure 3.2a). Intriguingly, careful inspection of the videos
revealed that the morphology of T. gondii-infected monocytes migrating on hCMEC/D3 cell
monolayers markedly differed from mock-infected cells (Figure 3.2b-d, Supplementary Figure
3.3, Supplementary Videos 1-3). As expected for cells crawling on endothelium, mock-infected
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monocytes moved by forming pointed pseudopodial structures at their leading edge that were
enriched in F-actin (Figure 3.2b-d, red arrows). In contrast, T. gondii-infected monocytes rarely
formed pseudopodial extensions. Instead, infected monocytes moved in an amoeboid manner,
typified by a rounded and flowing morphology, and frequently produced spherical membrane
protrusions (Supplementary Figure 3.2b, yellow arrows). A pronounced F-actin-rich leading
edge was typically absent in migrating infected monocytes, and their membrane protrusions
instead appeared to be stabilized by subsequent F-actin recruitment into membrane protrusions
(Figure 3.2b,d), consistent with the established dynamics of bleb-based motility (159). To
quantify these differences, we scored the number of structures consistent with pseudopodia
(defined by pointed morphology) and blebs (defined by rounded morphology and delayed F-actin
recruitment) formed by monocytes (Figure 3.2c-d). T. gondii-infected monocytes formed
significantly fewer pseudopodia and more blebs than mock-infected control monocytes (Figure
3.2c-d).
In summary, although T. gondii-infected monocytes migrated efficiently over
hCMEC/D3 endothelial cells, their morphology was strikingly inconsistent with canonical
adhesion-based vascular crawling and instead reminiscent of reports of amoeboid or bleb-driven
motility (122,159).
T. gondii infection enhanced monocyte migration through collagen-rich tissues
The amoeboid morphology of migrating parasitized monocytes led us to hypothesize that
the parasite may be activating a mode of motility similar to that of integrin-independent
leukocyte migration through tissue interstitium (122). To test this possibility, we used a simple
migration assay (123) where cells are allowed to migrate through 3-D matrices of polymerized
collagen I, the primary component of tissue interstitial space (160). We generated 3-D renderings
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from Z-stack images of fluorescently-labeled THP-1 monocytes captured after migration into
collagen I matrices (Figure 3.3a-b, top), and used automated cell identification to quantify the
number of monocytes that penetrated into the matrix, and their relative vertical positions (Figure
3.3a-b, bottom). Infection increased the number of THP-1 monocytes that penetrated into
collagen matrices and the distance they migrated (Figure 3.3a-d). Enhanced migration of infected
THP-1 cells was observed whether 3-D migration was spontaneous or chemokinetically
stimulated with MCP-1 chemokine (Figure 3.3c-d). Infection also enhanced the migration of
primary human monocytes, RAW 264.7 macrophages, and murine bone marrow-derived
macrophages in collagen I matrices (Supplementary Figure 3.4), confirming the robustness of
this phenotype.
To better reflect the complex composition and architecture of tissue interstitial space, we
next adapted a method previously used to analyze DC interstitial migration through ex vivo
dermal ear sheets (122,161). Briefly, we labeled the vessels in the interstitial space of ex vivo
murine ear dermis by laminin staining, and then collected time-lapse microscopy images of
RAW 264.7 macrophages crawling within the dermis (Figure 3.3e-f). As in the collagen I
matrices, infection stimulated macrophage migration within ear dermis, significantly increasing
both the distanced traveled and velocity of migrating RAW macrophages (Figure 3.3g-h). Taken
together, our results show that T. gondii infection enhances macrophage migration in collagenrich tissue substrates.
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Migration of infected cells relies upon host Rho/ROCK and parasite ROP17
Having determined that T. gondii-infected monocytes overwhelmingly fail to traverse
endothelial barriers yet robustly migrate through collagen-rich tissues, we next sought to
determine the mechanism by which infection specifically enhances tissue migration.
Monocytes and macrophages can migrate through 3-D substrates via amoeboid and
mesenchymal modes with differing integrin-dependencies (121,138,139), and these different
modes can be separated based on their sensitivity to specific inhibitors of actin-based motility.
We used the compounds ML-141, NSC-23766, and Rhosin to respectively disrupt Cdc42, Rac,
and Rho signaling (162) (Figure 3.4a), and found that only inhibition of Rho was disruptive to 3D migration of parasitized THP-1 monocytes (Figure 3.4b). Consistent with a key role for Rho
signaling, we further found that inhibition of the Rho effector ROCK by the compound Y-27632
significantly decreased the distance traveled by parasitized monocytes (Figure 3.4b). In contrast,
we found that inhibition of the Rho effector PKC-α with the compound Gӧ 6976 (163) had a
minimal effect on 3-D migration (Figure 3.4b). Rho/ROCK signaling often lead to motility via
formin-mediated actin polymerization. Further supporting the relevance of Rho and ROCK in
our system, we found that SMIFH2 inhibition of formins (164) had a significantly larger
dampening effect on the migration of infected monocytes than CK-666 (165) inhibition of the
actin-nucleator Arp2/3 (Figure 3.4b). The migration of infected RAW 264.7 macrophages was
also blocked by Y-27632 inhibition of ROCK (Supplementary Figure 3.4e), suggesting a shared
mechanism of enhanced migration in human monocytes and murine macrophages. Consistent
with their inefficient endothelial adherence, infected cells migrate via an integrin-independent
amoeboid mode that is highly reliant on Rho/ROCK signaling.
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The ability of Rho inhibition to block migration of infected monocytes implies that T.
gondii enhances motility by acting at or upstream of Rho. T. gondii secretes an array of effector
proteins into host cells, several of which interfere with innate immunity(120,166). None of these
effectors have been shown to target the host cytoskeleton, and the T. gondii genome does not
encode any obvious analogs to Rho GEFs or GAPs (http://toxodb.org). However, the T. gondii
kinases ROP17 and ROP18 phosphorylate the SWI region of immunity-related GTPases (IRGs)
(167). As Rho GTPases also contain SWI regions (168), we hypothesized that perhaps they could
also be targeted by ROP18 or ROP17 (167).
By infecting RAW 264.7 macrophages with Δrop5, Δrop17, and Δrop18 T. gondii, we
determined that rop17 is required for parasites to enhance penetration into and travel through
collagen matrices (Figure 3.4c-d). Only ROP17 was required for parasites to enhance
macrophage migration, with Δrop5 and Δrop18 parasites enhancing migration as effectively as
wild-type parasites (Figure 3.4c-d). No synergy with ROP18 was evident, as Δrop17Δrop18
parasites blocked migration no more effectively than Δrop17 parasites (Figure 3.4c-d). ROP17
has been previously shown to perform kinase activity in vitro (167), but the necessity of its
kinase activity for any of its proposed functions remains untested. The catalytic triad of ROP17
is conserved and easily identifiable (Figure 3.4e) (169). We generated parasites where Δrop17 is
complemented with either a cMYC-tagged wild-type ROP17 allele, or one of two mutant alleles
where disruption of the catalytic triad residues (K312A, D436A) should ablate kinase activity.
ROP17WT-cMYC, ROP17K312A-cMYC, and ROP17D436A-cMYC are all expressed at similar
levels and accumulate as immature pro-proteins and a mature processed variant (Figure 3.4f).
Complementation of Δrop17 with ROP17WT-cMYC restored collagen migration, while both
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catalytic triad mutants phenocopied Δrop17 (Figure 3.4g), demonstrating the necessity of ROP17
kinase activity for enhancing macrophage migration,
If ROP17 functions by activating Rho signaling, this could also lead to inhibition of Racdependent process such as endothelial adherence and transmigration via Rho-Rac crosstalk
(170). Accordingly, we next tested if ROP17 is involved in parasite inhibition of monocyte
adherence to our hCMEC/D3 model BBB. Parasites lacking rop17 inhibited the adherence of
THP-1 monocytes, although the observed decrease was significantly less dramatic than that
caused by infection with wild-type T. gondii (Figure 3.4h). This result suggests that ROP17
contributes to the inhibition of monocyte endothelial adherence, but another parasite effector
likely required for more complete suppression. In contrast, ROP17 appears essential for T. gondii
to enhance migration through collagen-rich 3-D substrates.
ROP17 ablation slows parasite dissemination and eliminates enhanced tissue migration of
infected monocytes in vivo
We then asked if ROP17-dependent enhancement of monocyte tissue migration alters
parasite dissemination in an in vivo murine model. Mice were infected subcutaneously with
luciferase-expressing T. gondii and intravital bioluminescence imaging was performed to assess
parasite dissemination. In mice infected with knockout (i.e. Δrop17::cLUC) vs. complemented
(i.e. Δrop17::cLUC/ROP17-cMYC) parasites, we found that ROP17-deficient parasites robustly
amplified at the injection site but spread more slowly, resulting in a lower parasite burden
compared to the complemented line as reflected by luminescence signal (Figure 3.5a-b).
Although subtle, the reduced tissue dissemination seen with the Δrop17 knockout led to a
significant enhancement in mouse survival (Figure 3.5c).
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ROP17 has been previously implicated as a minor partner in ROP18/ROP5-mediated
defense of the parasitophorous vacuole from host IRGs (167). We accordingly asked whether the
deficient spread and amplification of knockout Δrop17::luc parasites could derive from enhanced
clearance of these mutants in macrophages. To test this, we infected mice intraperitoneally so
that parasite dissemination would be aided by peritoneal flow into the systemic circulation, but a
robust immune response including macrophage defense would still be encountered. In this
system, we observed no consistent difference between knockout and complemented parasites, as
assessed by either intravital imaging or mouse lethality (Figure 3.5d-f). We further established
that Δrop17::cLUC parasites establish normal parasitophorous vacuoles and do not exhibit
impaired growth in IFNγ/LPS-activated RAW 264.7 murine macrophages (Supplementary
Figure 3.4). Collectively, these findings imply that the attenuation of Δrop17::luc parasites
derives primarily from deficiencies in dissemination.
Finally, we used intravital two-photon imaging to examine whether ROP17 is critical for
T. gondii to enhance monocyte tissue dissemination in vivo. We focused on the spleen as it is the
major tissue reservoir of monocytes (171) and it is readily infected by T. gondii during natural
infections (29). We found that wild-type T. gondii infection increased the migration of
CX3CR1GFP/+ monocytes significantly, enhancing their median track speed, mean square
displacement, and median track straightness (Figure 3.6a-c, left). In contrast, Δrop17 infection
had no statistically significant effect on measured monocyte motility parameters (Figure 3.6a-c,
right). Consistent with our observations of motility in the BBB model (Figure 3.2), infected
monocytes migrated in vivo with a flowing amoeboid morphology suggestive of integrinindependent interstitial migration (Figure 3.6e-f). Our intravital imaging data strongly support
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the model that ROP17-dependent enhancement of monocyte tissue migration promotes parasite
dissemination through tissues in vivo.
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Discussion
T. gondii parasites have been proposed to exploit the migration of leukocyte Trojan
horses to gain access to the CNS, although compelling supporting data for this model is lacking.
Here we show that T. gondii infection profoundly impaired monocyte transmigration across a
model BBB in vitro and integrin-dependent adherence to endothelial ligands. In contrast,
infection enhanced monocyte locomotion over endothelial surfaces and interstitial migration
through 3-D tissues, both in vitro and in vivo. Enhanced tissue migration was driven by
activation of a Rho/ROCK-mediated pathway typically associated with integrin-independent
amoeboid interstitial migration. We further identified the secreted T. gondii kinase ROP17 as
essential for T. gondii to activate monocyte tissue migration. By infecting mice with rop17deficient T. gondii, we show that loss of parasite-enhanced monocyte tissue migration leads to
slower parasite dissemination kinetics and prolonged mouse survival. In summary, we show that
T. gondii dissemination is promoted by ROP17-dependent activation of interstitial tissue
migration in infected monocytes, while integrin-dependent processes that lead to endothelial
traversal are strongly inhibited.
Although integrins were once thought to be pivotal players in all forms of leukocyte
migration, elegant genetic work in mice has established that integrin-independent migration is
possible within tissues (122). When leukocytes interact with vasculature, integrins function as
both adhesins that enable stable leukocyte adherence to endothelial ligands and as critical forcetransducers that convert retrograde actin polymerization into forward movement (172). However,
the 3-D environments of tissue interstitial space de-emphasize the importance of adhesion. In
such tissue environments, low affinity interactions with the surrounding matrix and Rho/ROCKdriven actin-based contractility can propel leukocytes forward in the absence of any
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contributions from integrins (122,172). Here we report that T. gondii infection of monocytes
simultaneously inhibits integrin-dependent processes and activates Rho-dependent tissue
motility. The overwhelming failure of infected monocytes to perform integrin-mediated
adherence to or transmigration through endothelium suggests that infected monocytes are illsuited to act as Trojan horses that deliver parasites across the BBB and into the CNS. Instead, we
speculate that enhanced tissue migration could carry infected monocytes via lymphatic drainage
into the circulation. Once in the circulation, parasites may egress from infected monocytes and
directly invade brain endothelium (30), a process that could perhaps be aided by infected
monocytes embolizing in small capillaries of the brain.
Our studies demonstrate that T. gondii programs monocytes to preferentially migrate
through tissues in an amoeboid manner by using the secreted kinase ROP17 to activate
Rho/ROCK- and formin-dependent processes. During natural infections, T. gondii first
encounters and infects leukocytes in the intestinal lamina propria (28). Our findings predict that
the parasite may activate the tissue migration of infected lamina propria monocytes in order to
rapidly escape this compartment. We focused on monocyte and macrophage motility due to the
abundance of infected monocytes in the blood (29). However, T. gondii can also alter DC
motility (96,97,153,154), and DCs are infected in the lamina propria, although again to a lesser
extent than monocytes and macrophages (28). The specific subsets of leukocytes that are the
primary target(s) of ROP17-mediated enhanced tissue migration in vivo remains a question for
further study. Consistent with a role in dissemination, we showed that T. gondii infection
enhanced in vivo migration of CX3CR1+ monocytes in the spleen, and that loss of ROP17dependent enhanced monocyte tissue migration delayed the dissemination of hypervirulent type I
T. gondii parasites. Similarly, ROP17 ablation was reported to cause a near complete loss of
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brain cyst formation in a cyst-competent type II T. gondii lineage (173), likely as a consequence
of reduced dissemination.
Our findings establish that catalytic activity of the secreted serine/threonine kinase
ROP17 is required for T. gondii to enhance monocyte tissue migration. Prior work theorized that
ROP17 forms a complex with the kinase ROP18 and regulatory pseudokinase ROP5, and
synergizes with these partners to ensure parasite survival within activated macrophages by
phosphorylating IRGs (167). In stark contrast to this IRG defense system, we found that when
enhancing monocyte migration, ROP17 functions completely independently of ROP5 and
ROP18. We presume that ROP17 enhances tissue migration by phosphorylating an unknown,
non-IRG target. We previously showed that ROP17 exhibits a strong preference for threonine
phosphorylation and slight preference for surrounding hydrophobic residues (167). Although
kinase targets cannot be easily predicted from substrate preference motifs, RhoA GTPase, Rho
GEFs VAV and GEF-H1, Rho GAP DLC1, and Rho GDI1 can all be phosphoregulated (174),
and are thus candidate substrates through which ROP17 could activate Rho-driven amoeboid
migration. Future elucidation of ROP17 substrates may provide exciting insights into both T.
gondii dissemination and the currently completely unknown mechanisms that prompt leukocytes
to adopt integrin-independent migratory strategies in vivo.
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Materials and methods
Parasite culture
T. gondii parasites were propagated in human foreskin fibroblasts (HFF) obtained from
the laboratory of John Boothroyd at Stanford University. Type II ME49 mCherry parasites were
used throughout Figures 1-3 unless otherwise indicated. All studies with ROP17 were performed
in a Type I RH Δku80 Δhxpgrt background. Source and generation details for all T. gondii strains
used are described in Supplementary Table 3.1.
Primary human monocytes
Primary human monocytes were obtained by flushing human peripheral blood from
leukoreduction (LRS) chambers provided by the Washington University School of Medicine
apheresis center, and then isolating monocytes via negative immunodensity selection with a
RosetteSep Human Monocyte Enrichment Cocktail (Stem Cell Tech) and Ficoll-Paque
sedimentation. To confirm successful isolation of monocytes, cells were analyzed for CD33 and
CD14 positivity by flow cytometry. Monocytes were cryopreserved immediately after harvest in
7.5% DMSO and 10% human serum. Upon thaw, primary monocytes were cultured in RPMI
supplemented with 10% human serum, 1% non-essential amino acids, 10 mM HEPES, and
100U/mL penicillin-1 µg/mL streptomycin.
Culture of primary human cells
Primary human aortic endothelial cells (HAEC) at passage 3 were obtained from Lonza
and cultured in fully-supplemented EGM-2 media (Lonza). HAEC from passages five to seven
were used in experiments. Primary human astrocytes were acquired from ScienCell and cultured
in Astrocyte Media (ScienCell) in flasks coated with 2 µg/cm2 collagen. Upon receipt, astrocytes
were cryopreserved at passage 1. Thawed aliquots at passage 3 or 4 were used for experiments.
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Bone marrow-derived macrophages
Bone marrow-derived macrophages (BMDM) were harvested from the femurs of
C57/BL6 mice with standard protocols, matured in BMDM Harvest Media (DMEM, 10% FBS,
5% horse serum, 40 µM L-glutamine, 100 µg/mL gentamicin, 20% L929-conditioned media),
and maintained in BMDM Maintenance Media (DMEM, 10% FBS, 5% horse serum, 40 µM Lglutamine, 100 µg/mL gentamicin, 10% L929-conditioned media).
Culture of cell lines
The human brain endothelial cell line hCMEC/D3(175) was obtained from the laboratory
of Robyn Klein at Washington University and grown as previously described(155) from passages
28 to 34. THP-1 monocytes were cultured in RPMI media supplemented with 10% FBS. RAW
264.7 macrophages were cultured in DMEM media supplemented with 10% FBS. HUVEC
EA.hy926 cells were obtained from ATCC and cultured in DMEM supplemented with 10% FBS.
All lines were confirmed as mycoplasma-negative with the e-Myco plus mycoplasma
PCR detection kit (Boca Scientific) upon acquisition.
Growth of hCMEC/D3 on polyacrylamide pads
To provide a soft substrate for cell growth, 0.4% polyacrylamide pads were prepared in
glass-bottom dishes as previously described(157), and then coated with 150 µg/mL rat collagen
I. Dishes were each seeded with 5x104 hCMEC/D3 and grown until confluence.
Microscopy
In vitro imaging studies were performed on a Axio Observer Z1 inverted microscope
(Zeiss) that features modules for conventional fluorescence, spinning disk confocal, and total
internal reflection fluoresecence (TIRF) microscopy. Conventional fluorescence images were
acquired with illumination from a Colibri LED light source (Zeiss) and ORCA-ER digital
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camera (Hammamatsu Photonics, Japan). Spinning disk and TIRF images were acquired using
illumination from 488 nm and 561 nm solid state lasers (Zeiss) and Evolve 512 Delta EMCCD
cameras (Photometrics). For all modules, Zen software (Zeiss) was used for image acquisition.
Time-lapse imaging of monocyte crawling on hCMEC/D3 endothelium
To quantify crawling, THP-1 monocytes were labeled with CellTrace Oregon Green 488
Carboxy-DFFDA (ThermoFisher), resuspended in Migration RPMI [phenol-red free RPMI
supplemented with 3% FBS, 1% non-essential amino acids (Gibco), and 10 mM HEPES] and
then infected with freshly-harvested T. gondii at an MOI of ~ 4.5 for 3-6 h. Just prior to imaging,
the hCMEC/D3 dishes were changed to Migration RPMI and then equilibrated for ten min at
37°C in the incubation chamber of an inverted microscope. Alternating conventional bright-field
and fluorescent images were captured at 1 min intervals over a 45-min period, using the abovedescribed spinning disk microscopy system with a 40x C-Apochromat water immersion
objective (N.A. 1.20). Automated tracking of individual monocytes’ centroids was performed
using Volocity software (PerkinElmer). To follow actin polymerization dynamics, cells were
transfected with F-Tractin-eGFP one day prior to imaging crawling on soft substrate-supported
hCMEC/D3. Actin polymerization videos were collected with the above spinning disc imaging
system, using five-sec intervals over 5-min periods. Structures consistent with pseudopodia or
blebs were manually counted.
Animals
All protocols requiring animals were approved by the Institutional Animal Care and Use
Committee at the Washington University in St Louis School of Medicine. Mice were housed in
Association for Assessment and Accreditation of Laboratory Animal Care Internationalapproved facilities at Washington University. CX3CR1GFP/+ mice were obtained from Jackson
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Laboratory or as generous gifts from Gwen Randolph (Washington University). CD1 mice were
purchased from Charles River Lab.
Intravital Two-Photon Imaging
Heterozygous CX3CR1GFP/+ mice were infected with 2-4x107 Cell Tracker Red CMPTXlabeled T. gondii via tail vein injection. Time-lapse imaging was performed with a custom built
2P microscope(176,177) equipped with a Chameleon Vision II Ti:Sapphire laser (Coherent) and
a 1.0 NA 20x water dipping objective (Olympus). SlideBook software (Intelligent Imaging
Solutions) was used to control laser scanning, image acquisition and z-step movements. In vivo
imaging of the spleen used a custom imaging chamber built in house(176). Mice were
anesthetized with 1.5% isoflurane in carbogen carrier gas and body temperature was maintained
with a warming plate. The skin was cut away over the spleen and a small incision made in the
peritoneal membrane to access the spleen. The spleen was lifted gently with forceps and a small
portion secured to thin plastic support with VetBond adhesive. The upper chamber plate was
lowered on to the tissue until contact was made with the coverslip and then the upper chamber
filled with water for imaging. The plastic support was then clipped to the upper chamber plate
with a hair pin to dampen movement artifacts. Small electrical heaters (resisters) attached to both
the upper and lower chamber plates were used to prevent the mouse from becoming
hypothermic. After the imaging preparation was completed and prior to imaging, the spleen was
examined under the microscope to confirm that blood flow was robust in sinuses and blood
vessels. CX3CR1-GFP cell migration was analyzed using 3D time-lapse imaging for up to
30min. Florescence was excited at 980nm and fluorescence emission detected by PMTs
simultaneously using 495nm and 560nm dichroic filters: Blue (<495nm, SHG collagen), green
(495-560nm, eGFP) and red (>560nm, CMTPX-Toxo). Auto fluorescence appears as mix of
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color (495-600nm) and thus can be discriminated from eGFP, and CMTPX. For time-lapse
imaging, we acquired a 500x500x60µm volume as 31 sequential 2 µm z-steps with a time
resolution of approximately 25s per time point and a X,Y resolution of 0.585 µm /pixel.
Intravital imaging focused on the red pulp at <100 µm below the surface. Multi-dimensional
data sets were exported as TIFFs and rendered in 3D using Imaris (Bitplane). Cell tracking and
data analysis were performed using Imaris (Bitplane) and Motility Lab (2ptrack.net). CX3CR1+
cells were identified by GFP signal and tracked in 3-D with an automated Imaris protocol.
Macrophages were manually excluded on the basis of morphology, and infected monocytes
manually identified by signal from the Cell Tracker Red dye. To assess track speed and mean
square displacement, infected monocytes were compared to all unambiguously uninfected
monocytes with verified accurate tracks from the same videos (RH-infected, N=34; Δrop17infected, N=41; uninfected, N>200). Straightness was assessed in only subsets of each
population chosen to have similar track durations (RH-infected monocytes, 74%, RH-uninfected
monocytes-42%, Δrop17-infected monocytes-95%, Δrop17-uninfected monocytes-66%).
In vivo infections and intravital luminescence imaging
8-10 week-old female CD1 mice were challenged intraperitoneally or subcutaneously in
the right rear flank with 200 parasites. Luminescence imaging was performed on mice
anesthetized with 2% isoflurane and injected intraperitoneally with D-luciferin (Biosynth AG)
(150mg/kg) with a Xenogen IVIS200 machine. Luminescence data was analyzed with Xenogen
Living Image software (Caliper Life Sciences).
Generation of transgenic monocytes and macrophages
THP-1 monocytes were transfected using the Amaxa 4D Nucleofection system (Lonza)
and cell line SG kit. For each transfection, 1 µg of plasmid DNA prepared with a PureLink
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HiPure Plasmid Midiprep Kit (Invitrogen) was used with 2x106 THP-1 monocytes. RAW 264.7
macrophages were transfected using Lipofectamine LTX with PLUS Reagent (Thermofisher)
and 7 µg DNA per plasmid, prepared with a NucleoBond Xtra Midi EF kit (Macherey-Nagel).
To generate a stable GFP-expressing line of RAW 264.7 macrophages, we introduced the
plasmids pSB-100 and pSB-Bi-GP, followed by selection with 5 µg/mL puromycin and
maintenance in 2.5 µg/mL puromycin (178).
Static adherence of monocytes to hCMEC/D3
Optical grade black 96-well plates were seeded with 1x105 hCMEC/D3 cells per well and
grown to confluence. The day prior to the adherence assay, hCMEC/D3 were activated overnight
with IFNγ (200 U/mL) and TNFα (200 U/mL) as indicated. THP-1 monocytes were labeled with
Cell Trace CFSE (Invitrogen), and then infected with T. gondii at an MOI of ~4.5. After four h
of infection, 10x105 monocytes per well were transferred to the pre-activated hCMEC/D3 and
allowed to adhere for 30 min at 37°C. Non-adherent monocytes were then removed by vigorous
rinsing, and the remaining adherent monocytes were fixed with 4% formaldehyde. Samples were
imaged with a Cytation 3 imager (Biotek), using automated cell finding from CFSE fluorescence
to locate focal planes. Approximately 80% of the well bottom was imaged, and Gen5 software
(Biotek) then used to quantify the number of adherent monocytes. Three independent
experiments were performed; each with 5-6 technical replicates per condition.
Integrin staining and TIRF microscopy
THP-1 monocytes were pre-infected T. gondii for 4 h (MOI=4) and then allowed to
adhere onto 50 µg/mL fibronectin-coated glass coverslip dishes (MatTek) for 30 min. Samples
were then gently rinsed with PBS and fixed for 10 min with ice-cold 4% formaldehyde in PBS.
Cells were permeabilized with 0.05% saponin and stained with monoclonal antibodies to LFA-1
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(TS2/4) or VLA-4 (9F10), followed by Alexa fluorophore-conjugated secondary antibodies.
Samples were imaged in PBS with the earlier-described TIRF microscopy system and a 100x oil
Plan-Apochromat (N.A. 1.46) objective. Tandem Z-stack series of the same cells were captured
with the earlier-described spinning disc system to visualize cells as infected or uninfected. TIRF
images were analyzed in Volocity software. Cell outlines were manually traced, and integrin foci
were identified using the Volocity Spot Finder function.
Transendothelial migration assays
Transendothelial migration (TEM) was quantified by allowing CFSE-labeled monocytes
to cross in vitro barriers of endothelial cells grown on 24-well format Falcon transwell permeable
supports with PET membranes and 8-micron pores. To create a flat surface for automated
imaging, 15 mm coverslips coated with 0.1% gelatin were placed in the basal chambers. After
allowing for transmigration, transwell inserts were removed and basal chambers were fixed with
0.4% formaldehyde. Rectangular grids covering about 90% of the basal chambers were then
imaged in medium-throughput format using a Cytation 3 (Biotek) plate imager with 10x
objective. Gen5 software (Biotek) was used to quantify the number of monocytes in each basal
chamber, as defined by size and fluorescence signal. Where indicated, chemotactic gradients
were generated by adding 100 ng/mL MCP-1 chemokine (Peprotech) to basal transwell
chambers. The hCMEC/D3 cell line was seeded onto transwell membranes pre-coated with 150
µg/mL rat collagen I, using 4-5x10^5 cells/cm2 and grown 5-7 days prior to TEM assays. Barrier
integrity was confirmed by measuring TEER with an EVOM2 Voltohmmeter (World Precision
Instruments). At the time of TEM assays, hCMEC/D3 cells typically achieved a TEER of 50-70
ohms/cm2.
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HAEC and HUVEC EA.hy926 were seeded 10 µg/mL fibronectin-coated transwell
membranes using 0.5-1x105 cells/cm2 and cultured for two days to generate a robust barrier.
Barrier integrity was confirmed by measuring transendothelial electrical resistance (TEER) with
an EVOM2 Voltohmmeter (World Precision Instruments). At the time of TEM assays, HAEC
cells typically achieved a TEER pf 40-50 ohms/cm2 and HUVEC a TEER of 80-120 ohms/cm2.
Three-dimensional collagen migration assays
Collagen matrices were prepared from Nutragen Type I Bovine Collagen (Advanced
BioMatrix) in 1X MEM Eagle supplemented with 7.5% sodium bicarbonate (pH 9) in opticalgrade black 96-well plates. Matrices were allowed to polymerize at 37°C for 60 min to
overnight, and then equilibrated ≥ 60 min in monocyte growth media supplemented with 3%
serum. In each well, 5x104 monocytes or macrophages pre-labeled with Cell Trace CFSE
(Invitrogen) and pre-infected with T. gondii (THP-1: MOI 4.5 with ME49 mCherry, 4 h; RAW
264.7: MOI 3 with ME49 mCherry) were allowed to migrate into the matrix. After overnight
migration at 37°C and 5% CO2, the samples were rinsed with PBS and fixed with 4%
formaldehyde. Z-stack image series of the monocytes captured within the collagen matrices were
captured with the above-described spinning disk microscopy system and an EC Plan-Neofluar
10x (N.A. 0.30) objective. Volocity software was used to generate 3-D renderings of the Z-stacks
and locate each monocyte using an automated Object Finding protocol based on fluorescence
intensity and cell size. Vertical distance migrated was calculated as the distance between the
centroid of the cell with the highest Z-position and every other cell.
Harvest of ex vivo dermal ear tissue and video microscopy of macrophage migration
Ventral ear sheets were harvested from 7-8 week old female BALB/C mice (Charles
River Lab) and stained for laminin (Sigma Aldrich) with AlexaFluor555-conjugated secondary
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antibody as previously described(161). GFP-expressing RAW macrophages were pre-infected
for 3-5 h with ME49 mCherry parasites or IC buffer control, and then harvested by gentle
scraping. Infected and uninfected macrophages were mixed together and given 20 min to crawl
into the dorsal side of an ear sheet. Ear sheets were then rinsed and imaged dorsal side-down in a
temperature (37°C) and CO2 (5%)-controlled chamber and the inverted spinning disc microscope
with a 20x EC Plan-Neofluar objective (N.A. 0.50). Videos were collected for 2 h at 3 min
intervals, each with Z-stacks spanning 50-80 micron in 5-micron increments. Zen (Zeiss)
software was used to correct drift with the Time Alignment function and deconvolve images with
a regularized inverse filter. A Volocity automated protocol was used to track all macrophages.
Every macrophage track was manually examined to confirm track accuracy and infection status.
Flow cytometry analysis of integrin expression and activation
THP-1 monocytes were infected with T. gondii at an MOI of ~4.5 for 3 h, or IC buffer in
equivalent volume. Monocytes were then pelleted and resuspended in Integrin Activation Buffer
(IAB) (Hanks’s Balanced Salt Solution, 1 mM Ca2+, 1 mM Mg2+, 20 mM HEPES, 0.5% FBS pH
7.4) and equilibrated at 37°C for 60 min. To activate integrins, monocytes were treated with 9
mM MnCl2 for 5 min at 37°C, then immediately transferred to ice. Live cells were stained for
integrin expression with primary monoclonal antibodies: activated LFA-1, mAb24 (Abcam);
activated VLA-4, mAb 12G10 (Abcam); LFA-1, mAb TS2/4 (Biolegend); VLA-4, mAb 9F10
(Biolegend), and Alexa-488-conjugated anti-mouse-IgG secondary antibody for detection. After
staining, cells were fixed with ice-cold 4% formaldehyde and stored at 4°C in PBS prior to
analysis with a BD-FacsCanto. Forward and side scatter gating was used to separate monocytes
from debris and extracellular parasites.
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Parasite growth in activated macrophages
RAW 264.7 macrophages were activated for 18 h with mouse IFNγ (10 U/mL) and LPS
(1 ng/mL), then infected with T. gondii. After 24 h, cells were fixed and parasites stained with
anti-DG52 antibody. The number of parasitophorous vacuoles present in five fields per technical
replicate was counted.
Parasitophorous vacuole staining
RAW 264.7 macrophages were infected with T. gondii. After fixation and
permeabilization with 0.05% saponin, cells were stained with anti-GRA7 (179).
Statistical Analysis
Data-sets were analyzed in Prism 7 (Graphpad). Normally distributed data were analyzed
with one-way ANOVA and Holm-Sidak’s multiple comparison’s test. Non-normally distributed
data were analyzed with Kruskal-Wallis Test and Dunn’s multiple comparison’s test. Whenever
applicable, two-tailed P-values were calculated and corrected for multiple comparisons. Twophoton data was analyzed in Motility Lab (http://2ptrack.net/) using two-tailed Wilcoxon’s tests
to assess significance.
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Figures, tables and legends

Figure 3.1: Transendothelial migration and adherence of infected monocytes.
(a-b) Transmigration of THP-1 (a) and primary human monocytes (b) through a hCMEC/D3
blood-brain barrier model. MCP-1 chemokine was added at 100 ng/mL to transwell chambers as
indicated. Prior to transmigration, monocytes were pre-infected with ME49-mCherry T. gondii.
Data is shown from one experiment representative of three independent experiments with the
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same outcome. Each symbol indicates an individual technical replicate (N=3-4/experiment).
Lines and error bars denote mean ± SD. Multiplicity-adjusted P -values from one-way ANOVA
and Holm-Sidak’s multiple comparison tests are shown in black (NS, P > 0.05); P -values from
unpaired t-tests are shown in blue. (c) Number of THP-1 monocytes adhered to hCMEC/D3
endothelial cell monolayers. Data derived from three independent experiments, each with 5-6
technical replicates. All quantities were normalized to the mean number of uninfected monocytes
adhering to non-activated hCMEC/D3. Error bars indicate mean ± SEM. Multiplicity-adjusted Pvalues from Holm-Sidak’s multiple comparisons tests are shown (NS, P > 0.05). (d-h)
Monocytes adhering to fibronectin-coated glass were stained with antibodies to VLA-4 (mAb
9F10) and LFA-1 (mAb TS2/4). (d) (top) Three-dimensional renderings from spinning disc
confocal imaging (top) of VLA-4-stained mock- (left) and T. gondii-infected (right) THP-1
monocytes, and (bottom) sample TIRF microscopy images of the same cells. White arrowheads
indicate spreading protrusions on the fibronectin surface. Scale bars = 5 micron. (e-h)
Quantification of the number of TIRF-detectable integrin foci (e,g) per monocyte, and total
integrin-contact-containing surface area occupied by individual monocytes (f,h). Each data point
shows an individual monocyte. Data were pooled from three independent experiments. Twotailed P -values from unpaired Mann-Whitney tests are shown.
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Figure 3.2: Locomotion of infected monocytes on model BBB.
(a) Displacement (top) and mean velocity (bottom) of THP-1 monocytes moving over
hCMEC/D3 endothelial monolayers, as quantified from 45 min time-lapse microscopy videos.
Data from three independent experiments were pooled (N= 8, 10, and 15 examples for mockinfected THP-1 monocytes; N= 12, 12, and 15 examples for infected). (b) Time lapse images of
crawling mock- (top) and T. gondii-infected (bottom) THP-1 monocytes expressing F-TractineGFP. Red arrows indicate F-actin-rich pseudopodia. Yellow arrows indicate membrane
swellings not enriched for F-actin. Images correspond to Supplementary Videos 1-2. (c-d) The
number of structures consistent with pseudopodia (c) and blebs (d) formed by THP-1 monocytes
during five min periods on hCMEC/D3. Images show representative pseudopodia (red arrows)
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and blebs (yellow arrows) and correspond to Supplemental Videos 1 and 3. Data from three
independent experiments were pooled. (a-d) Data points denote individual monocytes, and lines
median values. Two-tailed P-values from unpaired Mann Whitney tests are shown. All images
show 10-micron scale bars and time in sec.
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Figure 3.3: Migration of infected monocytes through 3D collagen-matrices and skin tissue.
(a-b) Schematic of collagen matrix assay with mock- (a) and infected (b) THP-1 monocytes. Top
images show three-dimensional renderings created from spinning disk confocal images of
fluorescently-labeled monocytes captured within collagen matrices. Red arrows indicate the
direction of migration. Bottom images show individual monocytes located with an automated
protocol. (c-d) After overnight migration, the absolute number of penetrant monocytes (c) and
vertical distance from each monocyte relative to the matrix top (d) was quantified for a single Zstack running through the center of each matrix. Plots show pooled data from three independent
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experiments, each with three technical replicates. The number of penetrant monocytes was
analyzed with one-way ANOVA and Holm-Sidak’s multiple comparison post-test and plotted as
means ± SD. Distance migrated was not normally distributed and accordingly analyzed with a
Kruskal-Wallis test and Dunn’s multiple comparison post-test and plotted with medians and
interquartile ranges. Multiplicity-adjusted P -values are shown. (e) 3-D rendering of dermal ear
sheet. Vessels (red) were stained for laminin. Macrophages were visualized by GFP, and T.
gondii by mCherry. Scale bar = 50 micron. Inset shows vessels traced in blue and intracellular
parasites in white. (f) Time-lapse series showing an infected macrophage migrating through ear
dermis, with vessels traced in blue and intracellular parasites in white on first image. Blue
arrowhead indicates infected macrophage. Yellow arrowheads indicate uninfected macrophages.
Scale bar 20 micron. (g-h) The trajectories of individual macrophages through ear dermis tracked
over a 2 h period. Displacement plots of uninfected (left) and infected (right) macrophages (g).
The total pathlength traveled (h) and average velocity (i) for each monocyte in the displacement
plots, with lines indicating mean values. Data was pooled from three independent experiments
(N=33 for both uninfected and infected monocytes) and analyzed using Mann-Whitney tests.
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Figure 3.4: Role of Rho/ROCK and ROP17 in enhanced tissue migration.
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(a) Schematic of Rho GTPase signaling and inhibitors (b) Vertical distance migrated by T.
gondii-infected THP-1 monocytes into a 0.8 mg/mL collagen I matrix loaded with 100 ng/mL
MCP-1 chemokine, during treatment with inhibitors schematized in (a) (10 µM ML-141, 100
µM NSC-23766, 100 µM Rhosin, 30 µM Y-27632, 1 µM Gӧ 6976, 100 µM CK-666, 30 µM
SMIFH2). Plot shows data from one experiment that is representative of three independent
experiments with the same outcome, each with three technical replicates. Median values and
interquartile ranges are indicated in red. (c-d) Migration of RAW 264.7 macrophages in 2
mg/mL collagen matrices after pre-infection with T. gondii of indicated genotype (c- number
penetrated macrophages, d- distance traveled). Plots show data from one experiment
representative of three independent assays, each with the same outcome and three technical
replicates. Black lines and error bars indicate mean ± SD (c), and red median and interquartile
ranges (d) (e) Schematic of ROP17 protein with catalytic triad residues and putative SUB2
processing site indicated. (f) Western blot of Δrop17 parasites expressing complementation
constructs ROP17WT-cMYC, ROP17D436A-cMYC, and ROP17K312A-cMYC, probed with antibodies
against cMYC and T. gondii MIC2. (g) Number of RAW macrophages migrated into a 2 mg/mL
collagen matrix after pre-infection with T. gondii of indicated genotype. Data is shown from one
experiment representative of three independent assays all with the same outcome. Lines indicate
mean, and errors bars SD. (h) Adherence of THP-1 monocytes to IFNγ/TNFα- (200U/mL)
stimulated hCMEC/D3 endothelial monolayers following pre-infection with T. gondii of
indicated genotype. Pooled data from three independent assays is shown, with figures normalized
to the mean number of adherent mock-infected monocytes in each experiment. Lines indicate
mean, and errors bars SD. Statistical significance was assessed with one-way ANOVA and
Holm-Sidak’s multiple comparison test for normally-distributed data (c, g, h), and Kruskal98

Wallis test and Dunn’s multiple comparisons test for non-normal distributions (b,d).
Multiplicity-adjusted P values are shown (n.s., P > 0.05).
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Figure 3.5: Role of ROP17 during in vivo infection.
(a-f) Female CD1 mice were infected subcutaneously (a-c) or intraperitoneally (d-f) with 200 T.
gondii of indicated genotype. Parasite burden and spread were monitored by intravital
luminescence imaging prior to fatality (a-b, subcutaneous- 8 days post-infection (dpi); d-e,
intraperitoneal- 6 dpi), and survival monitored daily (c,f). Pooled data from three independent
subcutaneous infections (5 mice/group) and two independent intraperitoneal infections (4-5
mice/group) are shown as total normalized luminescence signal in individual mice (b,e) and
survival curves (c,f). Luminescence data was analyzed by Mann-Whitney test, and mouse
survival by Gehan-Breslow-Wilcoxon test (n.s., P > 0.05).

100

Figure 3.6: In vivo motility of splenic monocytes infected with WT and rop17 parasites.
(a-f) Intravital two-photon spleen imaging was performed 2-4 h after CX3CR1GFP/+ mice were
infected i.v. with 2-4x107 wild-type or Δrop17 T. gondii labeled with Cell Tracker Red CMPTX.
(a-c) Median track speed (a), mean square displacement (b) of all tracked CX3CR1GFP/+
monocytes, and median track straightness of the motile subset (c) is plotted (left: wild type (WT)
T. gondii infections; right: Δrop17 infections). Shaded areas indicate SEM for mean square
displacement (b). Medians and interquartile ranges are shown in colored bars, with min/max
values indicated by black lines for track speed (a) and straightness (c) plots. Pooled data from
three mouse infections per parasite genotype is shown (N=34, WT-infected monocytes; N=41,
Δrop17-infected monocytes, N>200, uninfected monocytes). Data were analyzed by two-tailed
Wilcoxon tests (n.s., P > 0.05). (d-f) Still frame images show migration of individual monocytes
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displaying typical morphology. Start and end positions of migrating monocytes are indicated by
yellow arrowheads (uninfected, d) and pink arrowheads (infected, e-f). Scale bars: 10 microns.
Time shown in min. Images correspond to Supplementary Videos 4-6.
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Supplementary Figure 3.1: Transendothelial migration.
(a) Number of THP-1 monocytes transmigrated through barriers composed of immortalized
hCMEC/D3, primary human aortic endothelial cells (HAEC), or immortalized EA.hy926 human
umbilical vein endothelial cells (HUVEC). (b) Number of THP-1 monocytes transmigrated
through hCMEC/D3 barrier following astrocyte co-culture as indicated. (c) Number of THP-1
monocytes transmigrated through hCMEC/D3 barrier following pre-infection with indicated T.
gondii strains. All panels show data from either two (a, HAEC cells, c, CTG parasites) or three
independent experiments with the same outcome. Each marker indicates an individual technical
replicate (N=3-4 / experiment). Lines and error bars denote mean ± SD. Multiplicity-adjusted P values from one-way ANOVA and Holm-Sidak’s multiple comparisons tests are shown in black
(NS, P > 0.05); P -values from unpaired t-tests are shown in blue. All indicated differences
between means were statistically significant in all independent experiments.
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Supplementary Figure 3.2: Integrin expression and conformation.
(a-f) Monoclonal antibodies were used to stain invariant VLA-4 (mAb 9F10) (a), invariant LFA1 (mAb TS2/4) (b), activated VLA-4 (mAb12G10) (c,e), and activated LFA-1 (mAb 24) (d,f).
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(c-d) Histograms of THP-1 monocytes activated by MnCl2 and stained with antibodies specific
to activated VLA-4 (c) and LFA-1 (d). (a-b, e-f) Data points show median fluorescence
intensities (MFI) calculated from each of three independent experiments. Lines and error bars
indicate mean and SD. Multiplicity-adjusted P -values from all calculated Sidak’s multiple
comparisons tests are shown (ns, P > 0.05).
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Supplementary Figure 3.3: Migration through collagen I matrix.
(a-f) Migration of primary human monocytes (a-b), RAW 264.7 macrophages (c-d), and murine
bone marrow-derived macrophages (e,f) into and through matrices of indicated collagen density,
following pre-infection with ME49-mCherry T. gondii or a buffer control. Pooled data from
three independent experiments, each with three technical replicates, is shown. The number of
penetrant monocytes was analyzed with one way ANOVA and Holm-Sidak’s multiple
comparisons post-test and plotted with means and standard deviations (a,c,e). The distance
migrated by monocytes was not normally distributed and accordingly analyzed with a Kruskal
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Wallis Test and Dunn’s multiple comparisons post-test, and plotted with medians and
interquartile ranges (b,d,f). For both analyses, multiplicity-adjusted P -values are shown.
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Supplementary Figure 3.4: Growth of Δrop17 parasites in RAW 264.7 macrophages.
(a) RAW 264.7 macrophages were labeled with CellTrace CFSE and infected overnight with T.
gondii of indicated genotype labeled with Cell Tracker Deep Red. Parasitophorous vacuoles
were stained with anti-GRA7 Scale bars: 5 micron. (b) Number of T. gondii vacuoles present
after 24 h of growth in IFNγ/LPS-stimulated RAW 264.7 macrophages. Plot shows pooled data
from two independent experiments, each with three technical replicates. (n.s., P > 0.05, unpaired
t-test).
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Table 3.1: T. gondii strains used in this study.
Name

Genotype

Source Details

CTG

(180)

GT1

(181)

ME49

ME49 Δhxpgrt::FLUC

(182)

ME49 mCherry

ME49 Δhxpgrt::FLUC
GRA1:MCHERRY,
DHFR:HXPGRT

This
study

RH

RH Δku80Δhxpgrt

(183)

VAND

Random integration
of
GRA1:MCHERRY,
DHFR:HXPGRT

(184)

Δrop17

RH Δku80 Δrop17::HXPGRT

(167)

Δrop17::luc

RH Δku80 Δrop17::cLUC

(167)

Δrop17 ROP17WT
-cMYC

RH Δku80
Δrop17::HXPGRT/ROP17WTcMYC

This
study

Δrop17 ROP17K312A
-cMYC

RH Δku80
Δrop17::HXPGRT/rop17K312AcMYC

This
study

Δrop17 ROP17D436A
-cMYC

RH Δku80
Δrop17::HXPGRT/rop17D436AcMYC

This
study

Δrop17::luc ROP17
-cMYC

RH Δku80
Δrop17::cLUC/ROP17-cMYC

This
study

Δrop5

RH Δku80 Δrop5::HXPGRT

(185)

Δrop18

RH Δku80 Δrop18::HXPGRT

(186)

Δrop17Δrop18

RH Δku80 Δrop17::cLUC
Δrop18::HXPGRT

(167)
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Δrop17
complemented with
wild-type ROP17
(pLD-14, pCAS9sgUPRT)
Δrop17
complemented with
ROP17K312A (pLD17, pCAS9sgUPRT)
Δrop17
complemented with
ROP17D436A (pLD16, pCAS9sgUPRT)
Δrop17::luc
complemented wild
wild-type ROP17
(pLD-14, pCAS9sgUPRT)

Table 3.2: Plasmids used in this study.
Stock Name

Short
Name
pSAG1:CAS9pCAS9GFP,U6:sgUPRT sgUPRT

Construction

Purpose

(187)

Induce double-stranded break at
UPRT locus

pUPRTFloxedDHFRTS*
pLD-08

Kevin Brown,
Addgene 100606
pROP17

Gibson assembly
of: vector
backbone
amplified from
pUPRTFloxedDHFR-TS
with LDO-73 and
LDO-74 and
ROP17 amplified
from RH genomic
DNA with LDO61 and LDO-62
Q5 mutagenesis of
pLD-08 using
LDO-65 and LD066

Construct for ROP17 expression in
T. gondii under native promoter

pLD-14

pROP17cMYC

pLD-16

pROP17D436AcMYC

Q5 mutagenesis of Construct for ROP17K312A-cMYC
pLD-14 using
expression in T. gondii under native
LDO-75 and
promoter
LDO-76

pLD-17

pROP17K312AcMYC

Q5 mutagenesis of Construct for ROP17D436A-cMYC
pLD-14 using
expression in T. gondii under native
LDO-77 and
promoter
LDO-78
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Construct for ROP17-cMYC
expression in T. gondii under native
promoter

Table 3.3: Oligonucleotides used in this study.
Stock Sequence
Name
LDO- TGTTGAGAAAGCGGTTCGGC
tgtgctcactggtggtagtg
61
LDO62
LDO65
LDO66
LDO75
LDO76
LDO77
LDO78

Purpose
Sense oligo to amplify ROP17
5’UTR with homology to
pUPRT-FloxedDHFR-TS

TCTCCCGCATGTCACGTGGC
ctgtaagtccgcgaagctg

Antisense oligo to amplify
ROP17 3’UTR with homology
to pUPRT-FloxedDHFR-TS
ctccttctgtaataaagccgc
Antisense oligo to amplify
ROP17 CDS starting before stop
GAACAAAAACTCATCTCAGAAGAGGATCTG Sense oligo to introduce cMYC
taatctgatgcggtcaatgc
tag before ROP17 stop codon
via Q5 mutagenesis
TGTTCATGGCgctGTGAAACTGC
Sense oligo to introduce D436A
SNP in ROP17 via Q5
mutagenesis
AGTCCGAACGCGTGGAAT
Antisense oligo to introduce
D436A SNP in ROP17 via Q5
mutagenesis
ATTCGCGCTGgcgATATTTGTTCAACGGGTG Sense oligo to introduce K312A
SNP in ROP17 via Q5
mutagenesis
GGTTGCCCTGTGGTGGGA
Antisense oligo to introduce
K312A SNP in ROP17 via Q5
mutagenesis
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Chapter 4: Conclusion and future directions

This chapter was composed by LLD. Comments from LDS were incorporated into the final
version.
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Conclusions
Toxoplasma gondii is an apicomplexan parasite capable of infecting a diverse array of
host cells and tissues. Infections are orally acquired upon the ingestion of parasite cysts within
undercooked meat or oocysts within contaminated food or water, and accordingly are initially
concentrated in the intestinal lamina propria. However, T. gondii systemically disseminates
during acute infections and the most severe manifestations of acute toxoplasmosis derive from
the parasite’s ability to access protected host compartments such as the central nervous system
and placenta.
Parasite spread relies on the intrinsic gliding motility of T. gondii, which allows
extracellular parasites to locomote within tissues to new host cells and invade diverse host cells
including migratory leukocytes. Gliding motility and host cell invasion have long been theorized
to be powered by a parasite actin-myosin motor (32). The development of improved tools for
inducible ablation of T. gondii genes had suggested the possible existence of invasion processes
that function independently of parasite actin (68,69). However, the essential and pleiotropic
nature of the T. gondii actin ACT1 complicated the assessment of whether ACT1 was specifically
required for parasite invasion of host cells.
Infected migratory leukocytes can also promote dissemination by shuttling intracellular
parasites to new host compartments as they traffic throughout the host. Monocytes have been
widely theorized as potential Trojan horses that could deliver intracellular T. gondii across the
blood-brain barrier and into the CNS (29,87,108). However, limited in vivo data supported this
model and in vitro approaches had not established whether infected monocytes could efficiently
traverse blood-brain barrier endothelium or tissue environments. The role that infected
monocytes were likely to play in advancing in vivo dissemination thus remained unclear.
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Parasite actin is critical for gliding motility and invasion
ACT1 depletion is not uniform in individual parasites and correlates with invasion defects
Previous studies developed a dimerized Cre-Lox system in which rapamycin induces
Cre-mediated excision ablates a floxed ACT1f allele and replaces it with a YFP cassette that
functions as a reporter for knockout parasites (68,69). During short term propagation, low levels
of residual gliding and cell invasion in Δact1 parasites were proposed to comprise evidence for
an ACT1-independent invasion pathway in T. gondii. However, because these studies did not
quantitatively assess the extent of ACT1 depletion in recently induced Δact1 parasites, the
degree to which these parasites resembled phenotypic nulls was uncertain.
The findings of my thesis confirm that inducible Δact1 parasites exhibited marked
impairment but not a complete block in all forms T. gondii motility: extracellular gliding, egress,
and host cell invasion (188). Importantly, the data presented here also show that ACT1 protein
content widely varied in individual parasites after inducible ACT1f excision (188). Inducible
Δact1 parasites identified by YFP expression contained significantly less ACT1 than control
parasites, but residual ACT1 was detectable up to five days following rapamycin induction of
excision. As parasites were cultured for longer time periods following rapamycin-induced ACT1f
excision, increasingly severe depletion for ACT1 and defects in invasion were observed. The
correlation between ACT1 depletion and invasiveness suggests that the residual ACT1 could be
functioning in invasion. Consistent with this interpretation, inducible Δact1 parasite invasion was
further blocked by the actin polymerization inhibitor cytochalasin D.
The wide variety in ACT1 protein content among both wild-type and Δact1 parasites was
surprising. The observation that individual Δact1 parasites retained detectable ACT1 protein so
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long after rapamycin-induced gene excision could be explained by two mechanisms. First, some
of the inducible knockouts staining strongly for ACT1 may represent parasites that
spontaneously excised ACT1f after the rapamycin induction period. Consistent with this
hypothesis, rare YFP-expressing parasites were observed in uninduced ACT1f parasites cultured
in vitro. Second, some portion of parasites may inherit unusually large subsets of ACT1 mRNA
or protein present before gene excision. These mechanisms would both be expected to occur very
infrequently. However, a requirement for ACT1 for both parasite division and host cell invasion
would also cause truly ACT1-ablated parasites to rapidly drop out of the population during in
vitro propagation. The resulting selection in favor of the rare Δact1 parasites with meaningful
residual ACT1 protein would increase their apparent prevalence in pools of Δact1 parasites.
Importantly, a portion of ACT1f-intact parasites that stained for ACT1 protein levels as low as
the mean content of induced Δact1 parasites was consistently detected, even as long as five days
after induction of ACT1f excision. This finding suggests that T. gondii parasites naturally express
a range of ACT1 protein levels, and that most parasites contain far more ACT1 protein than is
necessary to power invasion. Accordingly, the ACT1 depletion in Δact1 parasites must be
extremely severe to truly approximate functional knockout.
A later study used a similar quantitative immunostaining approach to estimate ACT1
protein content in inducible Δact1 parasites and consistent with my findings, reported detectable
ACT1 staining above background up to four days post rapamycin-induced gene excision (189).
Surprisingly, this report failed to detect overlap in the ACT1 content of individual ACT1f-intact
and Δact1 parasites at any time-points later than 36 hours past rapamycin induction of gene
excision (189). However, this study used an automated approach to staining quantification that
relied solely on YFP expression to identify parasites (189). This approach would not detect
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recently-excised knockouts expressing only low levels of YFP, such as spontaneous late excisers.
The methods that were used in this later study to ensure that a representative range of YFPnegative ACT1f-intact parasites were identified for quantification in this system were not
specified, but a range of ACT1 staining intensity was detected in control parasites (189), as in
my studies. The discrepancy between my studies and this report might derive from the use of
different antibodies or independently-generated ACT1f inducible excision lines. However, the
most likely explanation is that the automated approach employed in this later study failed to
identify all parasites in the analyzed populations, with the result of excluding low-YFPexpressing Δact1 parasites and low-staining ACT1f-intact parasites from analysis. Relatedly, the
automated subtraction of putative background signal in the later paper may have also
inadvertently eliminated true signal from the analysis.
Actin is specifically involved in the penetration step of host cell invasion
Initial reports of inducible Δact1 parasites proposed that a defect in moving junction
formation by these mutants implied that ACT1 promotes invasion by mediating attachment (69)
rather than providing motive force during host cell penetration as was initially theorized by the
glideosome model (17). My thesis work found that Δact1 parasites exhibited no defect in
adherence to fibroblasts rendered resistant to parasite invasion via glutaraldehyde fixation (188).
However, a subsequent study reported that Δact1 parasites exhibited profound defects in
adherence to collagen under shear stress conditions (189). It thus appears possible that under
some conditions, ACT1 helps promote parasite adherence to substrates. However, my work also
used a rapid invasion pulse to capture many parasites in the process of invasion, and thereby
demonstrated that Δact1 parasites are able to form moving junctions (188). Moreover, video
microscopy showed that inducible Δact1 parasites invading fibroblasts initiated the invasion
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process but were significantly delayed in host cell entry, with a subset failing to complete
invasion at all (188). Importantly, video analysis of invasion also showed that about half of the
Δact1 parasites invaded fibroblasts with normal kinetics, consistent with a model where a portion
of these mutants are not strongly depleted for ACT1 and thus not functionally knockouts (188).
The ability of Δact1 parasites to form moving junctions and initiate invasion suggests that they
stably adhere under standard culture conditions, and in such conditions exhibit defects specific to
the penetration stage of invasion, presumably by working with myosin to generate force.
My thesis establishes that ACT1 plays a specific role in the penetration step of T. gondii
invasion, and that ACT1-independent invasion pathways are unlikely to robustly function in T.
gondii parasites. The possible existence of a very low efficiency ACT1-independent invasion
pathway in T. gondii cannot be formally excluded. However, such a pathway appears unlikely to
be an important contributor to host cell invasion given its negligible ability to compensate for the
loss of ACT1-dependent invasion. The variable levels of ACT1 expression in single parasites
and inconsistency of inducible Cre-Lox-mediated excision efficiency suggest that a more
decisive answer to this question would require different technology, for example the auxininducible rapid protein degradation system recently adapted to T. gondii (190).

T. gondii activates monocyte tissue migration, but inhibits integrin-dependent adherence
and transendothelial migration
Because they are the most abundantly infected circulating leukocyte in murine models of
toxoplasmosis (29), monocytes have been proposed as Trojan horses that could deliver
intracellular T. gondii parasites across the blood-brain barrier and into the brain (87,108). Several
studies supported this theory by showing that T. gondii infection can manipulate monocyte
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motility, specifically leading to decreased integrin-mediated adherence (106,107), enhanced
velocity and pathlength of crawling (108), and a net neutral impact of transendothelial migration
(108), all observed in an in vitro model based upon human umbilical vein endothelial cells
(HUVEC). However, no previous reports had considered the ability of infected monocytes to
traverse the highly specialized endothelium that comprises the blood-brain barrier, or tissue
environments representative of the intestinal lamina propria where T. gondii first encounters
monocytes.
Infection inhibited integrin-dependent processes
My thesis work used transwell systems to assess the ability of infected monocytes
traverse barriers composed of the human brain endothelial cell line, hCMEC/D3 (175). Contrary
to the prediction of a simple Trojan horse model of T. gondii CNS invasion, I found that T.
gondii infection severely inhibited the ability of monocytes to traverse this model blood-brain
barrier. This result was generalizable across many T. gondii strains, the monocytic cell line THP1 and primary human monocytes, and endothelial barriers composed of primary and
immortalized cells from CNS and peripheral tissues. Notably, I observed very limited
spontaneous transmigration of monocytes across HUVEC, which likely accounts for the failure
of a previous study to detect significant parasite inhibition of monocyte transmigration in an
analogous system (108). Integrins are well-established as key players in the transendothelial
migration cascade, functioning as both adhesins and force transducers (110). The failure of
infected monocytes to transmigrate through endothelial barriers likely stems from a failure to
successfully perform the processes that enhance avidity during integrin-mediated adherence, as I
observed that infected monocytes ineffectively adhered to endothelial substrates and failed to
mobilize integrins to ligand-contacting poles.
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In vivo, the blood-brain barrier is a complex system composed of many cell types and
subjected to mechanical stress from blood flow. To better reflect this complexity, I further tested
our phenotype in a hCMEC/D3-astrocyte co-culture system that more faithfully models the
blood-brain barrier (155), and still observed T. gondii inhibition of monocyte transendothelial
migration. Physiological transendothelial migration also occurs under conditions of shear stress,
which promotes selectin engagement preceding integrin activation (110,125) and might
somehow relieve defects in the integrin-mediated adherence and subsequent transendothelial
migration. However, a separate study does confirm my findings of faulty integrin-mediated
adherence in infected monocytes under shear stress conditions (107). Admittedly, my in vitro
model likely does not recapitulate several further features of the blood-brain barrier relevant to
toxoplasmosis in vivo, for example, the inflammatory state induced by infection, presence of
pericytes and extracellular matrix in addition to endothelial cells and astrocytes, and formation of
a more robust barrier. Accordingly, if infected monocytes have a specific preference for
traversing blood-brain barrier endothelium, this may not be triggered by my in vitro model.
Infected monocytes use an amoeboid migratory mode suited to tissue migration
I consistently observed that although very ineffective at transendothelial migration,
infected monocytes were very active cells. When monocytes migrated on top of endothelial
substrates, T. gondii infection led to enhancements in velocity and pathlength traveled. This
enhanced motility is consistent with previous reports analyzing migration over HUVEC under
shear stress conditions (108). However, because integrins are theorized to be critical force
transducers during vascular crawling (128,129), this observation seemed inconsistent with
infection blocking integrin-mediated adherence. Close examination of videos of the motility of
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migrating infected monocytes revealed dramatic amoeboid morphological changes markedly
inconsistent with typical monocyte vascular crawling.
Leukocytes have been previously shown to migrate through tissue interstitium in an
integrin-independent mode characterized by amoeboid morphology and reliance on Rho-driven
contractility for negotiation of small pores (121,122). I found that infected monocyte efficiently
migrated through an in vitro collagen matrix model of tissue interstitium. Consistent with an
integrin-independent mode that relies on Rho/ROCK signaling to formin-mediated actin
polymerization, the migration of infected monocytes was potently blocked by inhibitors of Rho,
ROCK, and formins. Physiological tissues are composed of many substrates arranged in complex
geometries not approximated by simple collagen I matrices (121). Accordingly, I further
established that infected monocytes migrate with enhanced efficiency through ex vivo murine
dermal sheets and in vivo splenic tissue.
T. gondii ROP17 is required for enhanced monocyte tissue migration and effective in vivo
dissemination
The critical role of monocytes in controlling acute toxoplasmosis (112,113) renders
monocyte ablation ill-suited to assessing whether monocytes also serve a specific role in
advancing T. gondii dissemination. To circumvent this limitation, I sought to identify parasite
factors required for the enhancement of monocyte tissue migration. My thesis work implicated
the secreted T. gondii kinase ROP17 in parasite-enhanced monocyte tissue migration. The data
presented in this dissertation show that Δrop17 parasites fail to enhance monocyte migration
through in vitro collagen matrix models of tissue, and splenic tissue in vivo. I further showed that
Δrop17 parasites disseminate more slowly in murine infection models when parasites are
introduced subcutaneously.
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ROP17 has been previously theorized to synergize with the kinase ROP18 and
pseudokinase ROP5 in defending the T. gondii parasitophorous vacuole from attack by host
immunity-related GTPases in activated macrophages (167). This model raises the possibility that
the attenuation of Δrop17 parasites could derive from a failure to survive clearance within
macrophages, rather than deficiencies in spread. However, ROP17 on its own appears to play a
very minor role in this defense, with single Δrop17 deletion parasites exhibiting negligible
defects in macrophage survival (167,173), a finding that I confirmed. I further showed that the
attenuation of Δrop17 parasites is linked to an infection route that emphasizes the role of tissue
dissemination. Mice infected subcutaneously with Δrop17 parasites exhibited delayed T. gondii
spread and enhanced infection survival. In contrast, intraperitoneal infections that featured
passive T. gondii spread via lymphatic drainage exhibited no significant change in either T.
gondii spread or mouse survival for Δrop17 parasites. Overall, my results suggest that Δrop17
parasites are specifically attenuated due to decreased dissemination efficiency. This conclusion
implies that ROP17-dependent enhancement of monocyte tissue migration likely promotes
parasite dissemination during in vivo infections. Consistent with this model, another study found
that ROP17 deletion in a moderately virulent T. gondii lineage used to study chronic infections
led to a complete loss of brain cyst formation, presumably caused by a failure of Δrop17
parasites to systemically disseminate (173).
Mechanism of ROP17 activation of monocyte tissue migration
ROP17 is a serine-threonine kinase discharged from T. gondii rhoptry organelles into the
host cell cytosol during invasion, and subsequently recruited onto the cytosolic face of the
parasitophorous vacuole membrane (167). The catalytic triad of ROP17 is conserved, suggesting
that ROP17 is likely a catalytically active kinase (169). Consistent with this prediction, previous
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work from our group demonstrated that ROP17 is catalytically active in vitro (167). My work
further determined that ROP17 kinase activity is required for T. gondii to enhance monocyte
tissue migration, by showing that complementation with rop17D436A and rop17K312A catalytic triad
mutants cannot restore the enhanced monocyte migration phenotype to Δrop17 parasites.
Previous work identified the switch I region of host immunity-related GTPases as
substrates for ROP17 and ROP18 phosphorylation (167). Because immunity-related GTPases are
not connected with leukocyte migration (191), ROP17 likely phosphorylates a different substrate
to activate tissue migration. I initially theorized that ROP17 could be involved in enhancing
tissue migration due to the common presence of switch I regions in immunity-related GTPases
and Rho GTPase (168). However, ROP17 could also activate Rho-dependent tissue migration by
acting on Rho regulators, for exampling enhancing activity of a Rho GEF or neutralizing a Rho
GAP or GDI, or even indirectly via Rho-Rac crosstalk (170) by potently inhibiting Rac activity.
Several Rho regulators including the GEFs VAV and GEF-H1, the GAP DLC1 and RhoGD11
are known to be phosphoregulated (174) and thus are appealing candidate substrates for ROP17.
However, phosphoregulation of Rho signaling pathway components has not been exhaustively
studied (174), suggesting the relevant target could easily have not been previously shown to be
phosphoregulated. Moreover, it remains possible that ROP17 functions far upstream of Rho,
such at the level of GPCR signaling, or targets a different pathway as my inhibitor-based analysis
of Rho/ROCK signaling may have been compounded by off-target effects. Future studies should
thus take an unbiased approach to identifying ROP17 substrates.
Whether ROP17 is likely to mediate tissue migration from the parasitophorous vacuole or
act earlier when still free in the host cytosol is uncertain. My working model is that ROP17 likely
phosphorylates a substrate involved in Rho signaling. Activated Rho typically functions at the
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plasma membrane (174). The parasitophorous vacuole to which ROP17 is recruited is derived
from host cell plasma membrane, but substantially modified (192). Whether Rho is present or
active on the parasitophorous vacuole membrane is uncertain. A series of N-terminal domains
that mediate recruitment of ROP18 to the parasitophorous vacuole are well-established (193) and
conserved in ROP17 (194). However, unlike in defense against vacuolar attack by host
immunity-related GTPases mediated by the ROP5-ROP18-ROP17 complex (193), there is no
intuitive intrinsic link between ROP17 promotion of tissue migration and parasitophorous
vacuole localization. Accordingly, future studies should attempt to define whether ROP17
localization to the parasitophorous vacuole is needed for effective enhancement of monocyte
tissue migration.
Infected monocytes promote dissemination by advancing parasite spread through tissues,
rather than across endothelial barriers
The failure of the motility of infected monocytes to support robust transendothelial
migration suggests that monocytes are ill-suited to act as Trojan horses that deliver T. gondii
across the blood-brain barrier. Consistent with this idea, another study reported that infected
monocytes adoptively transferred to recipient mice readily trafficked to the brain, but
overwhelmingly remained in the vasculature and did not enter the brain parenchyma (30). This
study proposed that CNS invasion is instead accomplished via the invasion of blood-brain barrier
endothelial cells by extracellular T. gondii present in the bloodstream, which replicate within the
endothelium and then subsequently egress into the parenchyma. Supporting this model, the study
reported the presence of extracellular T. gondii parasites in the blood of mice fed tissue cysts and
used intravital two-photon imaging to capture instances of blood-brain barrier invasion by
parasites introduced intravenously (30). Whether these parasites approached the blood-brain
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barrier as extracellular parasites or were delivered within leukocytes remains uncertain, as the
intravital imaging assays did not include labeled leukocytes.
One intriguing hybrid of the direct parasite invasion of the blood-brain barrier model with
the Trojan horse dissemination model is that infected monocytes could shuttle intracellular
parasites throughout the bloodstream and thereby protect parasite cargo. Stalling or embolizing
of infected monocytes in small capillaries could then provide an opportunity for parasites to
egress out and directly invade the neighboring endothelium. Consistent with this model, a recent
study suggested that endothelial adherence can prompt early T. gondii egress from monocytes
(195). This model could also explain observations that T. gondii within the CNS tend to be found
near small vessels (30,37).
I propose that the primary function of monocytes in advancing T. gondii dissemination is
allowing parasites to rapidly move within and out of tissues (Figure 4.1). For example,
immediately after traversing intestinal epithelium, T. gondii parasites encounter lamina propria
monocytes and macrophages (28). This population includes many CX3CR1-expressing
macrophages that develop from inflammatory monocytes (115). Using intravital imaging, I
showed that T. gondii infection enhanced the interstitial migration of CX3CR1-expressing
monocytes in the spleen, suggesting that migration of CX3CR1+ lamina propria cells is likely to
be similarly enhanced by infection. Enhanced migration in infected CX3CR1-expressing
monocytes and descendant macrophages and DCs could enhance their entry into collecting
lymphatics, or travel through lymph nodes and thus possibly increase the typically very low
frequency of lymph node exit through efferent lymphatics (93). This route would eventually lead
infected cells to the bloodstream via the lymphovenous valve (196) (Figure 4.1). Upon entering
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the bloodstream, infected monocytes might then release parasites to invade endothelial cells and
subsequently egress into tissues such as the brain as outlined above.
Notably, I did not test whether other leukocytes exhibited ROP17-dependent enhanced
migration in vivo, or whether ROP17-dependent enhanced migration was relevant to parasite
dissemination in a murine system that models natural infection routes with oral cyst inoculation.
Future studies should test whether ROP17 promotes parasite dissemination after oral cyst
inoculation.
Follow-up studies could then assess whether specific leukocyte types are targeted by
ROP17-mediated enhanced migration. Monocytes are generally thought of as circulating cells
that differentiate into macrophages or dendritic cells upon entering tissues. However, evidence
suggests that at least some monocytes can extravasate into resting tissue, acquire antigen and
transport it to lymph nodes without substantially differentiating (197). Accordingly, future work
should test whether ROP17 activation of tissue migration is more potent in monocytes,
macrophages, or dendritic cells, and further assess whether ROP17-enhanced migration of any of
these cell types is particularly efficient at promoting in vivo dissemination after oral cyst
inoculation. If undifferentiated monocytes are relevant targets in vivo, it would be further
interesting to assess whether ROP17 activation of tissue migration is accompanied by pressure to
differentiate into macrophages or dendritic cells. Finally, as CCR2+ Lyc6hi inflammatory
monocytes are specifically implicated in controlling acute toxoplasmosis (112,113), it would also
be interesting to ascertain whether this specific monocyte subset is a target of ROP17-dependent
enhanced migration.
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Infected decouples matching of monocyte migratory mode to environment
Because all leukocytes express integrins that recognize ligands displayed in essentially all
mammalian tissues, integrin-independent migration is presumably never forced in vivo by the
impossibility of integrin-mediated adherence. However, integrin-independent migration may
allow leukocytes migrate in a more rapid or energy efficient manner by overcoming the need for
robust frictional forces or extensive cycles of adherence and de-adherence from substrates (129).
Accordingly, leukocytes likely migrate through tissue interstitium in vivo in a hybrid fashion that
incorporates different migratory modes as dictated by the immediate environments encountered
(198,199). This plasticity is reflected by in vitro studies showing that macrophages match the
adhesion-dependence of their migratory mode to the variety of 3-D matrix encountered
(138,139).
The data presented here indicate that T. gondii-infected monocytes migrate in an
amoeboid manner even if presented with endothelium that should promote highly-adhesive
integrin-dependent migration, as it is inherently ill-suited to be traversed in an amoeboid mode.
This observation suggests that the parasite can interfere the matching of the host leukocytes’
migratory strategy to environment. The mechanisms that control the transitions between
leukocyte migratory modes are as yet unknown (199). Further investigations of the mechanism
by which T. gondii ROP17 activates amoeboid migration in monocytes may provide insights into
mechanisms that regulate the initiation of amoeboid migration in leukocytes. In addition, my
findings identify toxoplasmosis as an intriguing physiological scenario where integrinindependent migration is not only possible if forced by genetic ablation of integrin functionality,
but preferentially performed. This finding provides compelling evidence that integrinindependent migration of leukocytes is not only possible in vivo, but physiologically relevant.
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Future Directions
This work shows that ROP17-dependent enhanced monocyte tissue migration promotes
the systemic dissemination of T. gondii parasites. Further investigations into the mechanism by
which ROP17 promotes monocyte tissue migration and the leukocytes and compartments most
relevant to this phenotype in vivo following oral infection will illuminate how T. gondii
disseminates and molecular mechanisms controlling leukocyte migration.
Mechanism of ROP17-enhanced tissue migration
This thesis established that ROP17 kinase activity allows T. gondii parasites to enhance
the migration of infected monocytes through tissues. This is presumably achieved via the
phosphorylation of a substrate other than the immunity-related GTPases previously identified as
ROP17 substrates. Previous work also showed that ROP17 strongly prefers to phosphorylate
threonine substrates, and has a subtle preference for surrounding hydrophobic residues (167).
However, this motif cannot predict ROP17 substrates. Moreover, serine-threonine kinases are
notoriously permissive in vitro. Accordingly, to define the mechanism by which ROP17 activates
tissue migration and identify authentic substrates of ROP17 relevant to this phenotype, I propose
three lines of investigation: testing whether ROP17 recruitment to the parasitophorous vacuole is
required for its activity in enhancing tissue migration, identifying ROP17 interaction partners in
live infected monocytes, and identifying ROP17 phosphorylation substrates in infected cells.
Parasitophorous vacuole targeting of ROP17
ROP18 contains an N-terminal series of three arginine-rich amphipathic helices (RAH
domains) that target ROP18 to the parasitophorous vacuole membrane (193,200). Unsurprisingly
given the function of ROP18 in defending the parasitophorous vacuole, disruption of this
localization also disrupts ROP18 function in defending T. gondii from clearance in macrophages
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(193). ROP17 similarly localizes to the parasitophorous vacuole (167) and contains a degenerate
series of three N-terminal RAH domains that are sufficient to target constructs to the
parasitophorous vacuole (194) (Figure 4.2). However, it is not immediately obvious that
concentration of ROP17 activity at the parasitophorous vacuole would be necessary or even
beneficial to enhance monocyte tissue migration.
ROP17 could influence Rho signaling by interacting with Rho or a Rho GTPase before
being recruited to the parasitophorous vacuole, or by recruiting substrates to the parasitophorous
vacuole where ROP17 would have access to substrates due to its situation on the membranes’
cytosolic face. The amoeboid morphology of infected cells with constrictions appearing in many
areas of the monocyte implies that signaling activity may not be constrained to the
parasitophorous vacuole. Intriguingly, ROP17 encodes two putative SUB2 cleavage motifs and
processing at the second motif would disrupt the first RAH domain (Figure 4.2). In preliminary
studies, I generated ROP17 point mutants where either SUB2 motif is individually disrupted.
Both SUB2 motif mutants were still processed into mature ROP17, indicating both motifs are
functional processing sites (data not shown). I hypothesize that the dual SUB2 motifs might
create two ROP17 variants for specific purposes: one to sit on the parasitophorous vacuole and
assist ROP18, and one to remain cytosolic and manipulate host Rho signaling.
To test these models, I propose to complement Δrop17 parasites with cMYC-tagged
ROP17 alleles where the arginines in the RAH domains are mutated to glutamates, as was
previously done with ROP18 (193). Immunofluorescence can then be used to verify that these
ROP17-RAH mutants traffic to rhoptries but are not recruited to the parasitophorous vacuole. I
expect that disruption of RAH arginines will eliminate recruitment of ROP17 to the
parasitophorous vacuole. If this is observed, monocytes infected with ROP17-RAH mutants can
128

then be used to test whether ROP17 variants that do not localize to the parasitophorous vacuole
are still able to enhance monocyte migration through collagen matrices. If parasitophorous
vacuole localization is important for enhancing monocyte migration, this can be used to narrow
potential substrates identified in later studies to proteins that localize to the PVM.
If parasitophorous vacuole localization disruption does not restrict the ability of ROP17
to enhance monocyte migration, a similar approach could be used with Δrop17 parasites
complemented with ROP17 disrupted for the individual SUB2 motifs. This approach would test
whether cleavage in the first RAH domain (resulting from cleavage at the second SUB2 motif)
abrogates ROP17 targeting to the parasitophorous vacuole and enhancement of monocyte
migration. If disruption of the second SUB2 motif and associated RAH domain is more
disruptive to ROP17-dependent enhanced monocyte migration than disruption of the first SUB2
site, this would suggest that the two SUB2 processing sites on ROP17 produce functionally
distinct ROP17 variants with roles likely determined by localization.
Identification of endogenous ROP17-interacting proteins
The permissive nature of serine-threonine kinase in vitro renders it challenging to
determine whether substrates phosphorylated in such systems represent true physiological
substrates. Accordingly, confirmation of interaction with ROP17 substrates under physiological
conditions is a critical condition for assessing the veracity of putative substrates.
In pilot studies, I attempted to use pulldown of a cMYC-tagged ROP17 allele expressed
by T. gondii to identify ROP17-interacting proteins in infected monocytes. Unfortunately, no
host proteins were consistently enriched in ROP17-pulldowns as assessed by mass spectrometry
of three independent experiments. The transient nature of kinase-substrate interactions makes
such interactions challenging to detect via pulldown. Kinase-dead alleles of the related kinase
129

ROP18 increased the stability of interaction with IRG substrates, presumably caused by delays in
the phosphor-transfer reaction trapping the substrate within ROP18 (186). However, both the
D436A and K312A kinase dead ROP17-cMYC constructs I generated were not able to
successfully pulldown ROP17 despite expressing well, rendering this approach intractable.
As an alternative approach better suited to identifying transient kinase-substrate
interactions, I propose BirA-mediated biotinylation of proteins in proximity of ROP17 in
infected monocytes. In this approach, the promiscuous biotin ligase BirA will be fused to ROP17
and used as bait to identify monocyte proteins that interact with ROP17 upon infection with
these ROP17-BIRA T. gondii. Proteins that come into the proximity of the ROP17-BIRA fusion
will be marked by biotinylation and can be detected by western blotting or mass spectroscopy
following affinity chromatography capture. This approach has been successfully used to identify
proteins present within the dense granules (201) and apical conoid compartment (190) of T.
gondii. As infection never leads to faulty adherence or amoeboid morphology in the fibroblasts
that T. gondii is routinely cultured in, it appears that this mechanism does not function in
fibroblasts. Accordingly, I propose to perform a parallel assay in infected fibroblasts.
Biotinylated proteins specific to or more abundantly labeled in monocytes than fibroblasts would
be considered high priority candidates. Because biotin proximity labeling will likely identify
many indirect interactions, high priority candidates would be further tested for ROP17-cMYC
interaction by pulldown.
Unbiased identification of ROP17 phosphorylation substrates in monocytes
I propose attempting three independent unbiased approaches to identify potential
substrates of ROP17 phosphorylation in infected monocytes or macrophages: the use of
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sequence-independent phospho-threonine antibodies, a chemical genetic strategy relying upon
manipulation of the ROP17 ATP gatekeeper pocket, and global phosphoproteomics.
In the simplest approach, I will collect lysates from RAW macrophages infected with T.
gondii and probe these samples with several commercially available phospho-threonine
antibodies. To identify events reliant on ROP17 phosphorylation, infection with wild-type RH T.
gondii will be compared to infection with both Δrop17 and kinase-dead Δrop17 rop17K312A
complemented parasites. To eliminate phosphorylation of immunity-related GTPases irrelevant
to this phenotype, Δrop18 parasites will also be used. Bands present or enriched in only
monocytes or macrophages infected with wild-type T. gondii, but not Δrop17, kinase-dead
rop17K312A, or Δrop18 parasites or uninfected controls would suggest ROP17 phosphorylation of
a non-IRG target and could be sent for mass spectroscopy for protein identification. This
approach is very simple to execute. Another advantage is that any detected phosphorylation
events would occur within live infected cells. The primary disadvantage is that many
phosphorylated threonine residues are detected by such antibodies and could easily mask the
relevant ROP17-dependent events. If ROP17 phosphorylates Rho or a Rho regulator as I
hypothesize, one strategy to circumvent this limitation could be performing a Rho pulldown on
infected RAW lysates prior to antibody probing, thereby decreasing sample complexity and
enriching for Rho and associated proteins.
If the antibody approach fails, I would then attempt a chemical genetic ATP gatekeeper
pocket strategy. Briefly, in this strategy, ATP analogs are used to label the substrates of kinases
engineered to accommodate these analogs via mutation of the gatekeeper residue of the ATPbinding pocket (202-204). In the presence of the ATP analogs introduced to semi-permeabilized
cells, the engineered kinase thiophosphorylates substrates, which can be subsequently alkylated
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and recognized by an thiophosphate ester-specific antibody (204). This approach has been
previously used by our group to identify substrates for the T. gondii kinase CDPK1, which is
highly unusual in that it naturally contains a glycine gatekeeper residue that is permissive to the
ATP analogs used in this strategy (205). Glycine and alanine can both function as permissive
gatekeeper residues. However, kinases often have to be engineered with compensatory mutations
to maintain functionality in the presence of a permissive alanine or glycine gatekeeper (206).
I have identified the gatekeeper residue of ROP17 via sequence alignment to c-Src
(Figure 4.2) and further determined that complementation of Δrop17 parasites with ROP17
mutant alleles featuring glycine or alanine gatekeepers can restore the enhanced collagen
migration phenotype (data not shown). This successful complementation suggests that ROP17
can tolerative permissive gatekeepers. However, the robustness of these ROP17 gatekeeper
mutants should be further confirmed with recombinant proteins with the in vitro kinase assay
previously used by our group to show ROP17 activity (167). Should these assays confirm the
activity of permissive gatekeeper ROP17 variants, I propose to introduce permissive ROP17
gatekeeper alleles into Δcdpk1 T. gondii to reduce background from naturally ATP-analog
permissive CDPK1. RAW macrophages can then be infected and used in the ATP analog and
alkylation schema outlined above, comparing Δcdpk1 T. gondii with and without permissive
ROP17 alleles. ROP17 substrates can be identified by western blotting with the alkylated
thiophosphate antibody and searching for bands present only upon expression of the permissive
ROP17. Substrate identities would then be determined via immunoprecipitation with the
alkylated thiophosphate antibody or an iodoacetyl resin that captures the labeled substrates (207),
as was performed for CDPK1 (205). Because this gatekeeper ATP analog labeling strategy is
performed under semi-permeabilized conditions, ROP17 will be exposed to many substrates
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never encountered under physiological conditions. Accordingly, any candidate substrates
identified from this approach would then be assessed for endogenous interaction with ROP17 in
live cells using either pulldown or biotin labeling.
As a final approach, I propose performing comparative global phosphoproteomics to
identify phosphopeptides that are enriched in monocytes infected with wild-type T. gondii,
relative to monocytes infected with kinase-dead ROP17K312A parasites. Due to their typical
extreme low abundance, detecting phosphoproteins by mass spectroscopy is challenging (208).
However, immobilized metal-ion affinity chromatography (IMAC) used in tandem with metal
oxide affinity chromatography protocols have been extensively refined, allowing for enrichment
of phosphopeptides from the background proteome sufficient enough to make global
phosphoproteomics tractable (208). SILAC approaches further enable comparative quantification
of events between samples (208). Notably, successful implementation of this strategy would
identify both direct ROP17 substrates and phosphorylation events caused by downstream
signaling cascades. Accordingly, it would again be critical to confirm direct interaction of
ROP17 with any putative substrates.
Candidate substrates from these approaches would be assessed for direct ROP17
interaction and then analyzed by mass spectroscopy for ROP17-dependent phosphorylation
comparing monocytes infected T. gondii expressing active and kinase-dead ROP17 alleles. To
aid in detecting phosphorylation events, sampling can be focused on peptides predicted to be
preferred by ROP17 as determined by a substrate motif previously generated by our group using
a positional peptide scanning array (167). Functional implications of any identified
phosphorylation events could then be further probed via the creation of corresponding
phosphomimetic mutations and analyzing resultant changes in monocyte migration.
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Assessing physiological roles of ROP17-enhanced tissue migration
The robust tissue migration of infected monocytes and macrophages suggests a role in
advancing parasite spread through tissues. I demonstrated that ROP17 promotes interstitial
migration of infected CX3CR1-expressing cells in the spleen in vivo. However, because parasites
first encounter monocytes in the intestinal lamina propria and rapidly spready beyond this
compartment, I hypothesize that the major in vivo role of enhanced monocyte tissue migration
lies in promoting parasite escape from the intestinal lamina propria.
To test this hypothesis, I propose assessing the dissemination of Δrop17 parasites
following oral inoculation with tissue cysts, which mimics the natural route of infection and
leads to parasite invasion of the lamina propria. Unfortunately, this study cannot be performed
with the ROP17 mutants used in my studies, as they were generated in a type I T. gondii
background that does not form the tissue cysts in mice that are required for oral inoculation.
Another group generated Δrop17 parasites in a type II background that forms tissue cysts in mice
(173). However, these mutants are also ill-suited to studying the lamina propria phase of
toxoplasmosis, as the deletion of ROP17 in this lineage led to a near complete loss of brain cyst
formation (173).
To circumvent these limitations, I propose generating regulatable ROP17 mutants in a
cyst-competent T. gondii strain. Our group recently reported that an auxin-inducible degron
(AID) system can be used to induce degradation of T. gondii proteins during murine infections
by administering auxin to mice infected with parasites expressing the auxin receptor TIR1 and an
AID-tagged knockdown target (209). To enable investigation of ROP17 function during natural
infections, I would introduce TIR1 into a cyst-competent type II ME49 T. gondii strain
developed in our lab that expresses both luciferase and mCherry. Subsequent introduction of a
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ROP17-cMYC-AID allele into the resulting strain would enable auxin-inducible degradation of
ROP17, which can be easily confirmed in vitro. To generate ROP17-deficient tissue cysts, this
strain could then be inoculated into mice. Intravital luminescence imaging can be used to follow
infection progression. Once parasites have colonized the CNS, auxin can be administered to the
mice to induce ROP17 degradation and ROP17-deficient tissue cysts harvested for use in
subsequent infections, in which auxin administration would be continued to maintain ROP17
degradation. Pitfalls to this approach include the possibility that TIR1/AID-induced ROP17
degradation would not be sufficiently severe to ablate ROP17 function, or that auxin may not
robustly penetrate the blood-brain barrier. If these issues are encountered, alternative strategies
could be pursued using a rapamycin-inducible dimerized Cre system already established in T.
gondii (68), tamoxifen-inducible Cre-ER technology (210), or expression of Cre or
CRISPR/Cas9 systems (187) under the expression of bradyzoite-specific T. gondii promoters
(211) that would delay Cre or Cas9 expression until parasites differentiate into bradyzoites.
Once a robust regulatable ROP17 mutant is created in a cyst-competent lineage, this
strain should be used to track parasite dissemination after oral cyst inoculation. I first propose
using intravital luminescence imaging to track parasite dissemination for 1 month following oral
inoculation of ROP17-deficient and control tissue cysts, coupled with daily administration of
auxin or a vehicle control to maintain ROP17 status. Intravital luminescence imaging will be
performed every 2 days for the first week, then every 5 days. After 30 days, mice will be
sacrificed, and brain cyst burden assessed. Previous studies assessing a type II Δrop17 mutant
introduced into mice via intraperitoneal injection reported a near complete loss of brain cyst
formation (173). Based upon my data suggesting that ROP17 promotes dissemination, I
hypothesize that the observed loss of brain cysts was caused by a failure of the Δrop17 parasites
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to systemically disseminate. I accordingly predict that in this experiment, type II ROP17deficient parasites introduced via cyst feeding will form no brain cysts, and intravital
luminescence will show that they either fail to exit the abdominal cavity or exit the abdominal
cavity with delayed kinetics and abundance. If the auxin-inducible strategy described above
succeeds, this approach could then be complemented by another study in which auxin
administration is discontinued after defined intervals to establish a time window in which
ROP17-promoted dissemination is most important.
I next propose to use regulatable ROP17 mutants in cyst competent lineages to identify
leukocyte subsets that differentially migrate in response to oral infection with ROP17-deficient
parasites. As above, mice will be orally inoculated with ROP17-ablated and control parasites. I
will then collect mesenteric lymph nodes, peripheral blood, and spleens at early time-points after
infection (1dpi, 2dpi, 3dpi, 5dpi). Samples will be split so that quantitative PCR can be used to
establish parasite burden (expected to be very low) in each compartment at these early time
points and flow cytometry used to identify infected leukocytes. Flow cytometry samples will be
co-stained with a panel of markers selected to identify leukocyte subtypes and define the
maturation status of any infected monocytes or monocyte-derived cells. The abundance of each
leukocyte type in each compartment will be compared in mice infected with ROP17-proficient
and ROP17-deficient T. gondii. I expect that leukocytes that are in vivo targets of ROP17activated tissue migration would migrate to the lymph nodes and spleen in less abundance or
with slower kinetics in ROP17-deficient parasite infections. After establishing the relevant
leukocytes under physiological conditions, high dose tissue cyst infections could then be
combined with intravital two-photon imaging to assess the in vivo motility of target infected
leukocytes in the lamina propria.
136

Final Remarks
This work shows that T. gondii parasites use ACT1-dependent gliding motility to power
productive invasion of diverse host cells, and ROP17-dependent activation of interstitial
monocyte migration to spread through tissues. Future studies investigating which leukocytes and
tissue compartments are targeted in vivo for ROP17-enhanced interstitial migration will
illuminate how Trojan horses contribute to systemic T. gondii dissemination. In addition, probing
the mechanism by which ROP17 manipulates monocyte migration such that a lowly-adhesive
amoeboid mode is strongly favored over integrin-dependent modes may reveal fundamental
mechanisms governing regulation of and transitions between leukocyte migratory strategies.
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Figures and legends

Figure 4.1: Model for monocyte contribution to T. gondii dissemination.
Infected monocytes inefficiently perform integrin-mediated adherence and transendothelial
migration (left) but migrate through interstitial tissues with enhanced efficiency (right).
Lymphatic drainage and eventual travel through the lymphovenous valve could allow migrating
infected monocytes to deliver T. gondii into both secondary lymphoid tissues and the
bloodstream.
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Figure 4.2: Annotated ROP17 amino acid sequence.
ROP17 amino acid sequence from genome sequence of type I T. gondii strain, GT1. Putative
signal peptide sequence is highlighted in red, SUB2 processing motifs in green, arginine-rich
amphipathic helices in blue, kinase catalytic triad residues in yellow, and the ATP gatekeeper
pocket residue in orange.
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